首页 » 细胞株Cell Lines 43-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net

细胞株Cell Lines 43-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net

  • 价  格:¥19200
  • 货  号:NTCC-CV43
  • 产  地:北京
点击询问我要采购
 竭诚为您服务!
BioVector NTCC典型培养物保藏中心
联系人:Dr.Xu, Biovector NTCC Inc.

电话:400-800-2947 工作QQ:1843439339 (微信同号)

邮件:Biovector@163.com

手机:18901268599

地址:北京

已注册
 

细胞株Cell Lines-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心


http://www.biovector.net


ID   HO104

AC   CVCL_E700

SY   H0104

DR   dbMHC; 48896

DR   ECACC; 88052082

DR   IHW; IHW9082

DR   IMGT/HLA; 11633

RX   PubMed=8307784;

WW   http://bioinformatics.hsanmartino.it/ecbr/cl82.html

CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   HO15.19

AC   CVCL_0311

SY   Ho15.19

DR   MCCL; MCC:0000204

RX   PubMed=9342182;

CC   Breed/subspecies: Fischer 344.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_T953 ! HET15

CA   Spontaneously immortalized cell line

//

ID   HO16.4C

AC   CVCL_T952

SY   HO16.4c

RX   PubMed=9342182;

CC   Breed/subspecies: Fischer 344.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_T954 ! HET16

CA   Spontaneously immortalized cell line

//

ID   HO275

AC   CVCL_W086

DR   Cosmic; 1522771

DR   GEO; GSM726270

RX   PubMed=21642991;

CC   Omics: SNP array analysis.

CC   Misspelling: 'NCI-H0275' in Cosmic 1522771.

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   HO301

AC   CVCL_E701

SY   H0301

DR   dbMHC; 48876

DR   ECACC; 88052055

DR   IHW; IHW9055

DR   IMGT/HLA; 10751

RX   PubMed=8307784;

WW   http://bioinformatics.hsanmartino.it/ecbr/cl55.html

CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   HOB-02-C1

AC   CVCL_F757

RX   PubMed=8725178;

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Conditionally immortalized cell line

//

ID   HOB1

AC   CVCL_J391

RX   PubMed=2159767;

RX   PubMed=7786033;

CC   Doubling time: 22 hours (PubMed=2159767).

DI   NCIt; C7873; Adult immunoblastic lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   HOB1/ADR2.0

AC   CVCL_J392

RX   PubMed=1360209;

CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).

DI   NCIt; C7873; Adult immunoblastic lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_J391 ! HOB1

SX   Male

CA   Cancer cell line

//

ID   HOB1/VCR0.1

AC   CVCL_J393

RX   PubMed=1360209;

CC   Selected for resistance to: ChEBI; CHEBI:28445; Vincristine (VCR).

DI   NCIt; C7873; Adult immunoblastic lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_J391 ! HOB1

SX   Male

CA   Cancer cell line

//

ID   HOB1/VCR0.5

AC   CVCL_II74

RX   PubMed=7786033;

RX   PubMed=7903440;

CC   Selected for resistance to: ChEBI; CHEBI:28445; Vincristine (VCR).

DI   NCIt; C7873; Adult immunoblastic lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_J391 ! HOB1

SX   Male

CA   Cancer cell line

//

ID   HOB1/VCR1.0

AC   CVCL_II75

RX   PubMed=7786033;

CC   Selected for resistance to: ChEBI; CHEBI:28445; Vincristine (VCR).

DI   NCIt; C7873; Adult immunoblastic lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_J391 ! HOB1

SX   Male

CA   Cancer cell line

//

ID   HOBIT

AC   CVCL_W632

SY   Human OsteoBlast-like Initial Transfectant

RX   PubMed=1373929;

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   HOC-1

AC   CVCL_5454

SY   HOC1

DR   Cosmic; 877478

DR   Cosmic; 1152558

RX   PubMed=4016745;

RX   PubMed=23415752;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Derived from metastatic site: Ascites.

DI   NCIt; C7550; Ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_5455 ! HOC-7

SX   Female

CA   Cancer cell line

//

ID   HOC-21

AC   CVCL_8692

DR   ChEMBL-Cells; CHEMBL3308669

DR   ChEMBL-Targets; CHEMBL614829

DR   Cosmic; 877479

DR   Cosmic; 1152559

RX   PubMed=4436993;

RX   PubMed=6163305;

RX   PubMed=6174649;

DI   NCIt; C7700; Ovarian adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   HOC-7

AC   CVCL_5455

SY   HOC7

DR   Cosmic; 923105

RX   PubMed=4016745;

RX   PubMed=23415752;

RX   PubMed=25230021;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: OCCP ovarian cancer cell line panel.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Derived from metastatic site: Ascites.

ST   Source(s): PubMed=25230021

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 9,11

ST   D16S539: 9

ST   D18S51: 14

ST   D21S11: 30,31.2

ST   D3S1358: 15

ST   D5S818: 11,12

ST   D7S820: 8,9

ST   D8S1179: 12,14

ST   FGA: 23,25

ST   Penta D: 13

ST   Penta E: 7,12

ST   TH01: 9.3

ST   TPOX: 8,11

ST   vWA: 14,16

DI   NCIt; C7550; Ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_5454 ! HOC-1

SX   Female

CA   Cancer cell line

//

ID   HOC-8

AC   CVCL_5456

SY   HOC8

RX   PubMed=3756872;

RX   PubMed=23415752;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Derived from metastatic site: Ascites.

ST   Source(s): PubMed=11416159

ST   Amelogenin: X

ST   D18S51: 13,17

ST   D21S11: 28,32.2

ST   D8S1179: 10,12

ST   FGA: 22

ST   TH01: 6,9.3

ST   vWA: 16,18

DI   NCIt; C7550; Ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   HOC1119

AC   CVCL_S689

SY   HOC 1119

RX   DOI=10.11277/stomatology1952.44.47;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   HOC119

AC   CVCL_8693

SY   HOC-119; HOC 119; HOC 1-19

DR   Cosmic; 1120709

RX   DOI=10.11277/stomatology1952.44.47;

RX   PubMed=10705089;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   HOC1208

AC   CVCL_8694

RX   PubMed=10705089;

WW   http://inhibitorlibraries.com/we-unearthed-that-the-development-of-oral-scc-cells-was-inhi

DI   NCIt; C129857; Gingival squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   HOC313

AC   CVCL_8695

SY   Hoc313; HOC-313

DR   CGH-DB; 363-2

DR   Cosmic; 930340

DR   Cosmic; 1046030

DR   Cosmic; 1123030

RX   PubMed=2654810;

RX   PubMed=12632084;

RX   PubMed=17052259;

RX   PubMed=17599052;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   HOC512

AC   CVCL_8696

SY   HOC 512

RX   DOI=10.11277/stomatology1952.44.47;

RX   PubMed=10705089;

DI   NCIt; C6064; Maxillary sinus squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   HOC519

AC   CVCL_8697

SY   HOC 519

RX   DOI=10.11277/stomatology1952.44.47;

RX   PubMed=10705089;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   HOC605

AC   CVCL_8698

DR   Cosmic; 1123033

RX   PubMed=1624295;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   HOC621

AC   CVCL_8699

DR   Cosmic; 1120710

RX   PubMed=10705089;

WW   http://inhibitorlibraries.com/we-unearthed-that-the-development-of-oral-scc-cells-was-inhi

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   HOC719

AC   CVCL_8700

DR   Cosmic; 1123034

RX   PubMed=11120485;

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   HOC719-NE

AC   CVCL_8701

RX   PubMed=11120485;

RX   PubMed=12632084;

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8700 ! HOC719

CA   Cancer cell line

//

ID   HOC719-PE

AC   CVCL_8702

RX   PubMed=11120485;

RX   PubMed=12632084;

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8700 ! HOC719

CA   Cancer cell line

//

ID   HOC815

AC   CVCL_8703

SY   Hoc815; HOC-815

DR   CGH-DB; 357-2

DR   Cosmic; 930341

DR   Cosmic; 1046031

DR   Cosmic; 1123031

RX   PubMed=1624295;

RX   PubMed=17052259;

RX   PubMed=17599052;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   HOC927

AC   CVCL_8704

DR   Cosmic; 1123035

RX   PubMed=1624295;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   HOCC

AC   CVCL_M684

RX   PubMed=15369135;

DI   NCIt; C4646; Gestational choriocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   HOCE

AC   CVCL_4840

DR   CLO; CLO_0050152

DR   BioSample; SAMN03472148

DR   RCB; RCB1514

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 8,9

ST   D16S539: 11,13

ST   D5S818: 10,11

ST   D7S820: 10,12

ST   TH01: 6,9

ST   TPOX: 11

ST   vWA: 14,18

DI   NCIt; C4646; Gestational choriocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   HOE6V

AC   CVCL_4J71

RX   Patent=US8835164;

CC   Registration: International Depositary Authority, Korean Cell Line Research Foundation; KCLRF-BP-00218.

CC   Transfected with: UniProtKB; P03126; HPV16 E6 (variant form).

DI   NCIt; C4028; Cervical squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1094 ! C-33 A

SX   Female

CA   Cancer cell line

//

ID   HOEF

AC   CVCL_4841

DR   CLO; CLO_0050883

DR   BioSample; SAMN03472199

DR   RCB; RCB1010

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8,12

ST   D16S539: 10,11

ST   D5S818: 10,12

ST   D7S820: 10,12

ST   TH01: 7

ST   TPOX: 8,9

ST   vWA: 17

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   HOFPAEC

AC   CVCL_6G14

SY   HPV16-transformed Ovine Fetal Pulmonary Artery Endothelial Cell line

RX   PubMed=10409236;

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].

CC   Miscellaneous: As no precise cell line name was given in the paper, we assigned the name based on the transformation method, the species of origin and the primary cell type name.

OX   NCBI_TaxID=9940; ! Ovis aries

CA   Transformed cell line

//

ID   HOG

AC   CVCL_D354

RX   DOI=10.1016/B978-0-12-333530-2.50005-8;

RX   PubMed=1329795;

RX   PubMed=14618099;

DI   NCIt; C3288; Oligodendroglioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   HOK-1

AC   CVCL_B403

RX   PubMed=1714884;

DI   NCIt; C4912; Bladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   HOK-16A

AC   CVCL_B404

SY   HOK16A; Human Oral Keratinocytes-16A

RX   PubMed=1330348;

RX   PubMed=1654226;

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_B405 ! HOK-16B

SX   Male

CA   Transformed cell line

//

ID   HOK-16A-BaP

AC   CVCL_6G58

RX   PubMed=1330348;

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).

CC   Transformant: ChEBI; CHEBI:29865; Benzo[a]pyrene.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B404 ! HOK-16A

SX   Male

CA   Transformed cell line

//

ID   HOK-16A-MSEE

AC   CVCL_6G59

RX   PubMed=1330348;

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).

CC   Transformant: ChEBI; CHEBI:23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B404 ! HOK-16A

SX   Male

CA   Transformed cell line

//

ID   HOK-16B

AC   CVCL_B405

SY   HOK16B; Human Oral Keratinocytes-16B

RX   PubMed=1330348;

RX   PubMed=1654226;

RX   PubMed=10675494;

RX   PubMed=12907203;

RX   PubMed=21868764;

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).

ST   Source(s): PubMed=21868764

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 9,12

ST   D16S539: 12

ST   D5S818: 9,10

ST   D7S820: 12

ST   TH01: 8,9

ST   TPOX: 8,11

ST   vWA: 17,19

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_B404 ! HOK-16A

SX   Male

CA   Transformed cell line

//

ID   HOK-16B-BaP

AC   CVCL_B406

RX   PubMed=1330348;

RX   PubMed=7784058;

RX   PubMed=10675494;

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).

CC   Transformant: ChEBI; CHEBI:29865; Benzo[a]pyrene.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B405 ! HOK-16B

SX   Male

CA   Transformed cell line

//

ID   HOK-16B-BaP-T1

AC   CVCL_B407

RX   PubMed=7784058;

RX   PubMed=10675494;

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).

CC   Transformant: ChEBI; CHEBI:29865; Benzo[a]pyrene.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B406 ! HOK-16B-BaP

SX   Male

CA   Transformed cell line

//

ID   HOK-16B-MSEE

AC   CVCL_6G60

RX   PubMed=1330348;

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).

CC   Transformant: ChEBI; CHEBI:23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B405 ! HOK-16B

SX   Male

CA   Transformed cell line

//

ID   HOKKAIDO

AC   CVCL_E702

DR   dbMHC; 48897

DR   ECACC; 94082241

DR   IHW; IHW9141

DR   IMGT/HLA; 11684

RX   PubMed=8307784;

WW   http://bioinformatics.hsanmartino.it/ecbr/cl141.html

CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   HOKN9

AC   CVCL_X902

SY   HOKN-9

RX   PubMed=10761702;

RX   PubMed=18704411;

DI   NCIt; C4033; Clear cell renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   HOKUG

AC   CVCL_8705

DR   CLO; CLO_0050937

DR   BioSample; SAMN03472263

DR   Cosmic; 877465

DR   Cosmic; 1152545

DR   RCB; RCB0657

RX   PubMed=1698374;

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 8,11

ST   D16S539: 9

ST   D5S818: 11

ST   D7S820: 8,11

ST   TH01: 6,9

ST   TPOX: 11

ST   vWA: 17,18

DI   NCIt; C40212; Cervical adenosquamous carcinoma, glassy cell variant

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   HOM-1

AC   CVCL_A611

SY   HOM 1; HOM1

RX   PubMed=158761;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   HOM-2

AC   CVCL_A612

SY   HOM 2; HOM2

DR   BTO; BTO:0003106

DR   dbMHC; 48898

DR   ECACC; 98092902

DR   IHW; IHW9005

DR   IMGT/HLA; 10755

RX   PubMed=158761;

RX   PubMed=7614994;

WW   http://bioinformatics.hsanmartino.it/ecbr/cl5.html

CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   HoMel-A1

AC   CVCL_T050

RX   PubMed=23982913;

CC   Derived from metastatic site: Skin.

CC   Breed/subspecies: Arabian.

OX   NCBI_TaxID=9796; ! Equus caballus

SX   Female

CA   Cancer cell line

//

ID   HoMel-L1

AC   CVCL_T051

RX   PubMed=23982913;

CC   Breed/subspecies: Grey Lipizzaner.

OX   NCBI_TaxID=9796; ! Equus caballus

SX   Male

CA   Cancer cell line

//

ID   HOMM

AC   CVCL_4842

SY   Human Okuno Malignant Melanoma

DR   CLO; CLO_0050928

DR   BioSample; SAMN03472147

DR   RCB; RCB1513

RX   PubMed=9777403;

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 10,11

ST   D16S539: 9

ST   D5S818: 10,11

ST   D7S820: 10

ST   TH01: 9

ST   TPOX: 8

ST   vWA: 17,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   HONE-1

AC   CVCL_8706

SY   Hone-1; HONE1; Hone1

DR   BioSample; SAMN03472391

DR   ChEMBL-Cells; CHEMBL3308670

DR   ChEMBL-Targets; CHEMBL614830

DR   Cosmic; 755506

DR   Cosmic; 944908

DR   Cosmic; 1017620

DR   Cosmic; 1300998

DR   Cosmic; 1322948

DR   Cosmic; 2366881

DR   GEO; GSM375844

DR   GEO; GSM378801

DR   GEO; GSM378802

DR   TOKU-E; 3587

RX   PubMed=2556716;

RX   PubMed=24991015;

CC   Problematic cell line: Seems to bear part of the HeLa genomic sequence; may be a derivative of HeLa and another cell of unknown origin (PubMed=24991015).

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: Deep RNAseq analysis.

CC   Misspelling: Occasionally 'HOME-1'.

ST   Source(s): PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 10,12

ST   D16S539: 9,10,11

ST   D18S51: 13,16

ST   D21S11: 27,30

ST   D3S1358: 15,18

ST   D5S818: 11,12

ST   D7S820: 10,12

ST   D8S1179: 12

ST   FGA: 18,21

ST   Penta D: 9,12

ST   Penta E: 17,20

ST   TH01: 6,9

ST   TPOX: 8,12

ST   vWA: 14,16

DI   NCIt; C3871; Nasopharyngeal carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   HONE-1/CPT30

AC   CVCL_M595

SY   CPT30

DR   ChEMBL-Cells; CHEMBL3307934

DR   ChEMBL-Targets; CHEMBL614470

RX   PubMed=12097280;

CC   Selected for resistance to: ChEBI; CHEBI:27656; Camptothecin (CPT).

DI   NCIt; C3871; Nasopharyngeal carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8706 ! HONE-1

SX   Male

CA   Cancer cell line

//

ID   HONE-1/CPT30R

AC   CVCL_M596

SY   CPT30R

RX   PubMed=12097280;

CC   Selected for resistance to: ChEBI; CHEBI:27656; Camptothecin (CPT).

DI   NCIt; C3871; Nasopharyngeal carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_M595 ! HONE-1/CPT30

SX   Male

CA   Cancer cell line

//

ID   HOON

AC   CVCL_IN52

RX   PubMed=3262645;

RX   PubMed=6230491;

CC   Doubling time: 24 hours (PubMed=3262645).

DI   NCIt; C3168; Childhood acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   HOP-1

AC   CVCL_J127

DR   ATCC; CRL-11881

RX   Patent=US5830651;

CC   Discontinued: ATCC; CRL-11881; probable.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Adult stem cell

//

ID   HOP-18

AC   CVCL_H642

SY   HOP 18; HOP18; Hop18

DR   BioSample; SAMN03472883

DR   ChEMBL-Cells; CHEMBL3307783

DR   ChEMBL-Targets; CHEMBL614809

DR   GEO; GSM206506

RX   PubMed=2536293;

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 8,12

ST   D16S539: 12

ST   D18S51: 15

ST   D21S11: 29

ST   D3S1358: 18,19

ST   D5S818: 9,11

ST   D7S820: 9,11

ST   D8S1179: 11,12

ST   FGA: 23,25

ST   Penta D: 13

ST   Penta E: 13

ST   TH01: 9,9.3

ST   TPOX: 8,11

ST   vWA: 19

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   HOP-19

AC   CVCL_H643

DR   ChEMBL-Cells; CHEMBL3308671

DR   ChEMBL-Targets; CHEMBL614832

RX   PubMed=2536293;

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   HOP-62

AC   CVCL_1285

SY   HOP 62; HOP62; Hop62

DR   BTO; BTO:0004080

DR   EFO; EFO_0006439

DR   BioSample; SAMN03471402

DR   ChEMBL-Cells; CHEMBL3307671

DR   ChEMBL-Targets; CHEMBL614643

DR   Cosmic; 875855

DR   Cosmic; 905972

DR   Cosmic; 974289

DR   Cosmic; 1092603

DR   Cosmic; 1146945

DR   Cosmic; 1175861

DR   Cosmic; 1305344

DR   Cosmic; 1995442

DR   Cosmic; 1998445

DR   Cosmic-CLP; 905972

DR   GDSC; 905972

DR   GEO; GSM50211

DR   GEO; GSM50274

DR   GEO; GSM206507

DR   GEO; GSM434275

DR   GEO; GSM750804

DR   GEO; GSM794404

DR   GEO; GSM799338

DR   GEO; GSM799401

DR   GEO; GSM846357

DR   GEO; GSM1153408

DR   GEO; GSM1181256

DR   GEO; GSM1181314

DR   GEO; GSM1374542

DR   IGRhCellID; HOP-62_02GEO

DR   SKY/M-FISH/CGH; 2896

RX   DOI=10.4172/2157-7145.S2-005;

RX   PubMed=2041050;

RX   PubMed=2536293;

RX   PubMed=17088437;

RX   PubMed=19372543;

RX   PubMed=23856246;

RX   PubMed=23933261;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=27807467;

RX   PubMed=28196595;

WW   https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm

WW   https://strap.nci.nih.gov/celline_detail.php?sample_id=13

WW   http://tcpaportal.org/mclp/

CC   Part of: KuDOS 95 cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: NCI60 cancer cell line panel.

CC   Doubling time: 39 hours (DTP).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; DOI=10.4172/2157-7145.S2-005; PubMed=19372543; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 12

ST   D16S539: 11,12

ST   D18S51: 14

ST   D19S433: 13,14

ST   D21S11: 30

ST   D2S1338: 19

ST   D3S1358: 14,18

ST   D5S818: 11

ST   D7S820: 10,12

ST   D8S1179: 13

ST   FGA: 22,24

ST   Penta D: 9,13

ST   Penta E: 10,19

ST   TH01: 8,9

ST   TPOX: 8,11

ST   vWA: 15,17

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   HOP-92

AC   CVCL_1286

SY   HOP 92; HOP92; Hop92

DR   BTO; BTO:0004085

DR   EFO; EFO_0006440

DR   BioSample; SAMN03471631

DR   ChEMBL-Cells; CHEMBL3308091

DR   ChEMBL-Targets; CHEMBL613889

DR   Cosmic; 687783

DR   Cosmic; 875856

DR   Cosmic; 897510

DR   Cosmic; 905973

DR   Cosmic; 974290

DR   Cosmic; 1044247

DR   Cosmic; 1092604

DR   Cosmic; 1146946

DR   Cosmic; 1175862

DR   Cosmic; 1305345

DR   Cosmic; 1312330

DR   Cosmic; 1995443

DR   Cosmic; 1998446

DR   Cosmic-CLP; 905973

DR   GDSC; 905973

DR   GEO; GSM50212

DR   GEO; GSM50275

DR   GEO; GSM206508

DR   GEO; GSM434299

DR   GEO; GSM750805

DR   GEO; GSM794405

DR   GEO; GSM799339

DR   GEO; GSM799402

DR   GEO; GSM846358

DR   GEO; GSM1153409

DR   GEO; GSM1153410

DR   GEO; GSM1181257

DR   GEO; GSM1181315

DR   GEO; GSM1669890

DR   IGRhCellID; HOP-92_02GEO

DR   SKY/M-FISH/CGH; 2810

RX   PubMed=2041050;

RX   PubMed=17088437;

RX   PubMed=19372543;

RX   PubMed=23856246;

RX   PubMed=23933261;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=27807467;

RX   PubMed=28196595;

WW   https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm

WW   https://strap.nci.nih.gov/celline_detail.php?sample_id=14

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: NCI60 cancer cell line panel.

CC   Doubling time: 79.5 hours (DTP).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; PubMed=19372543; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 12

ST   D16S539: 12

ST   D18S51: 12,18

ST   D19S433: 13

ST   D21S11: 30

ST   D2S1338: 19,23

ST   D3S1358: 18

ST   D5S818: 12

ST   D7S820: 8,10

ST   D8S1179: 14 (PubMed=19372543)

ST   D8S1179: 9,14 (PubMed=25877200)

ST   FGA: 19,21

ST   Penta D: 10

ST   Penta E: 12

ST   TH01: 9,9.3

ST   TPOX: 8,11

ST   vWA: 15

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   HOPC 1F/12

AC   CVCL_3515

SY   HOPC-1F/12

DR   CLO; CLO_0003793

DR   ATCC; TIB-13

CC   Breed/subspecies: BALB/c.

DI   NCIt; C21631; Mouse plasmacytoma

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   HOR

AC   CVCL_E703

DR   dbMHC; 48899

DR   ECACC; 88052053

DR   IHW; IHW9053

DR   IMGT/HLA; 10757

RX   PubMed=8307784;

WW   http://bioinformatics.hsanmartino.it/ecbr/cl53.html

CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   Horse

AC   CVCL_9124

DR   CLO; CLO_0003794

DR   ATCC; CRL-6583

WW   http://www.grsykes.com/pdf/dna_species_id_notes.pdf

CC   Problematic cell line: Misidentified. Originally thought to be of horse origin but found to be from hamster (see WWW link).

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Miscellaneous: Even if it was not a misidentified cell line, it would probably win the award of the dummest name for a cell line! (hope the originator of this cell line never reads this comment).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

SX   Sex undetermined

CA   Undefined cell line type

//

ID   HOS

AC   CVCL_0312

DR   BTO; BTO:0003904

DR   CLO; CLO_0003795

DR   CLO; CLO_0050810

DR   EFO; EFO_0002196

DR   MCCL; MCC:0000205

DR   CLDB; cl1702

DR   CLDB; cl1706

DR   CLDB; cl7155

DR   ATCC; CRL-1543

DR   BCRC; 60308

DR   BCRJ; 0339

DR   BioSample; SAMN01821560

DR   BioSample; SAMN01821729

DR   BioSample; SAMN03471393

DR   CCLE; HOS_BONE

DR   CCRID; 3111C0001CCC000038

DR   ChEMBL-Cells; CHEMBL3308811

DR   ChEMBL-Targets; CHEMBL614736

DR   Cosmic; 687928

DR   Cosmic; 759899

DR   Cosmic; 907060

DR   Cosmic; 931037

DR   Cosmic; 931910

DR   Cosmic; 1044082

DR   Cosmic; 1070840

DR   Cosmic; 1074391

DR   Cosmic; 1176621

DR   Cosmic; 1529902

DR   Cosmic-CLP; 907060

DR   ECACC; 87070202

DR   GDSC; 907060

DR   GEO; GSM170248

DR   GEO; GSM185087

DR   GEO; GSM185088

DR   GEO; GSM320827

DR   GEO; GSM827319

DR   GEO; GSM879208

DR   GEO; GSM887088

DR   GEO; GSM888159

DR   GEO; GSM1669891

DR   GEO; GSM1676300

DR   GEO; GSM1701635

DR   ICLC; HTL04003

DR   IFO; IFO50106

DR   IGRhCellID; HOS

DR   IZSLER; BS TCL 69

DR   RCB; RCB0992

RX   PubMed=2823272;

RX   PubMed=12645653;

RX   PubMed=15150091;

RX   PubMed=19787792;

RX   PubMed=21519327;

RX   PubMed=22460905;

RX   PubMed=26351324;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-420.html

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; ECACC; JCRB; RCB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 12

ST   D16S539: 10,13

ST   D5S818: 13

ST   D7S820: 11,12

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 18

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   HOS [Dog osteosarcoma]

AC   CVCL_L356

RX   PubMed=9673952;

CC   Doubling time: 42.0 +- 0.1 hours (PubMed=9673952).

CC   Breed/subspecies: Mixed breed.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Male

CA   Cancer cell line

//

ID   HOS-CCR5

AC   CVCL_1H19

SY   HOS.CCR5

DR   NIH-ARP; 3519-30

CC   Transfected with: HGNC; 1606; CCR5.

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1H17 ! HOS-pBABE-puro

SX   Female

CA   Cancer cell line

//

ID   HOS-CD4

AC   CVCL_W650

SY   HOS.CD4

DR   NIH-ARP; 3313-13

CC   Transfected with: HGNC; 1678; CD4.

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0312 ! HOS

SX   Female

CA   Cancer cell line

//

ID   HOS-CD4-CCR1

AC   CVCL_1D94

SY   HOS-CD4-CCR-1; HOS-CD4.CCR-1; HOS.CD4.CCR1; HOS.CD4.CKR-1

DR   NIH-ARP; 3314-198

RX   PubMed=8649511;

CC   Transfected with: HGNC; 1678; CD4.

CC   Transfected with: HGNC; 1602; CCR1.

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_W650 ! HOS-CD4

SX   Female

CA   Cancer cell line

//

ID   HOS-CD4-CCR2b

AC   CVCL_1D95

SY   HOS-CD4-CCR-2B; HOS-CD4.CCR-2B; HOS.CD4.CCR2b

DR   NIH-ARP; 3315-229

RX   PubMed=8649511;

CC   Transfected with: HGNC; 1678; CD4.

CC   Transfected with: HGNC; 1603; CCR2.

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_W650 ! HOS-CD4

SX   Female

CA   Cancer cell line

//

ID   HOS-CD4-CCR3

AC   CVCL_1D96

SY   HOS.CD4.CCR3; HOS.CD4.CKR-3

DR   NIH-ARP; 3316-230

RX   PubMed=8649511;

CC   Transfected with: HGNC; 1678; CD4.

CC   Transfected with: HGNC; 1604; CCR3.

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_W650 ! HOS-CD4

SX   Female

CA   Cancer cell line

//

ID   HOS-CD4-CCR4

AC   CVCL_1D97

SY   HOS.CD4.CCR4

DR   NIH-ARP; 3317-231

RX   PubMed=8649511;

CC   Transfected with: HGNC; 1678; CD4.

CC   Transfected with: HGNC; 1605; CCR4.

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_W650 ! HOS-CD4

SX   Female

CA   Cancer cell line

//

ID   HOS-CD4-CCR5

AC   CVCL_1D98

SY   HOS-CD4.CCR5; HOS.CD4.CCR5; HOS.CD4-CKR5

DR   NIH-ARP; 3318-326

RX   PubMed=8649511;

CC   Transfected with: HGNC; 1678; CD4.

CC   Transfected with: HGNC; 1606; CCR5.

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_W650 ! HOS-CD4

SX   Female

CA   Cancer cell line

//

ID   HOS-CD4-Fusin

AC   CVCL_1D99

SY   HOS-CD4.Fusin

DR   NIH-ARP; 3319-368

RX   PubMed=8649511;

CC   Transfected with: HGNC; 1678; CD4.

CC   Transfected with: HGNC; 2561; CXCR4.

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_W650 ! HOS-CD4

SX   Female

CA   Cancer cell line

//

ID   HOS-CD4-pBABE-puro

AC   CVCL_1E00

SY   HOS-CD4.pBABE-puro; HOS.CD4.pBABE-puro

DR   NIH-ARP; 3320-14

RX   PubMed=8649511;

CC   Transfected with: HGNC; 1678; CD4.

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_W650 ! HOS-CD4

SX   Female

CA   Cancer cell line

//

ID   HOS-CXCR4

AC   CVCL_1H18

SY   HOS.CXCR4

DR   NIH-ARP; 3518-313

CC   Transfected with: HGNC; 2561; CXCR4.

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1H17 ! HOS-pBABE-puro

SX   Female

CA   Cancer cell line

//

ID   HOS-pBABE-puro

AC   CVCL_1H17

SY   HOS.p.BABE-puro

DR   NIH-ARP; 3517-36

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0312 ! HOS

SX   Female

CA   Cancer cell line

//

ID   HOSC1

AC   CVCL_IW50

RX   PubMed=25193510;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   HOSE 11-12

AC   CVCL_7671

SY   HOSE11-12

DR   BTO; BTO:0004435

RX   PubMed=15489894;

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   HOSE 17-1

AC   CVCL_7672

SY   HOSE17-1

DR   BTO; BTO:0004437

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   HOSE 6-3

AC   CVCL_7673

SY   HOSE6-3

DR   BTO; BTO:0004436

RX   PubMed=7796885;

RX   PubMed=15489894;

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   HOSE1-E7/hTERT

AC   CVCL_E232

RX   PubMed=15956975;

CC   Transfected with: HGNC; 11730; TERT.

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E7].

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   HOSONUMA

AC   CVCL_E704

SY   HOSONUM

DR   dbMHC; 48900

DR   ECACC; 94082229

DR   IHW; IHW9130

DR   IMGT/HLA; 11673

RX   PubMed=8307784;

WW   http://bioinformatics.hsanmartino.it/ecbr/cl130.html

CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Misspelling: Occasionally 'HONOSUMA'.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   HOTC-3

AC   CVCL_8707

SY   HOTC 3; HOTC3; Human Ovarian Teratocarcinoma Cell line-3

RX   CelloPub=CLPUB00050;

RX   PubMed=6174649;

DI   NCIt; C8110; Ovarian teratoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   HOTHC

AC   CVCL_8708

DR   CLO; CLO_0050950

DR   BioSample; SAMN03472267

DR   RCB; RCB0662

RX   PubMed=10457904;

RX   PubMed=17022149;

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 8

ST   D16S539: 12

ST   D5S818: 12

ST   D7S820: 8

ST   TH01: 6

ST   TPOX: 8

ST   vWA: 14,16

DI   NCIt; C3878; Thyroid gland undifferentiated (anaplastic) carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   HOTHC-SF

AC   CVCL_8709

DR   CLO; CLO_0050947

DR   RCB; RCB0690

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 8

ST   D16S539: 12

ST   D5S818: 12

ST   D7S820: 8

ST   TH01: 6

ST   TPOX: 8

ST   vWA: 14,16

DI   NCIt; C3878; Thyroid gland undifferentiated (anaplastic) carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8708 ! HOTHC

SX   Female

CA   Cancer cell line

//

ID   HOUA-I

AC   CVCL_3867

SY   HOUA-1; HOUA

DR   CLO; CLO_0050886

DR   BioSample; SAMN03472265

DR   Cosmic; 713498

DR   Cosmic; 1241348

DR   Cosmic; 1622897

DR   RCB; RCB0659

RX   CelloPub=CLPUB00051;

CC   Doubling time: ~50 hours (CelloPub=CLPUB00051).

CC   Misspelling: 'HOOUA' in Cosmic 1241348.

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 14,15

ST   D13S317: 13,14,15

ST   D16S539: 9,13,14

ST   D5S818: 12,14,15

ST   D7S820: 10,11,12

ST   TH01: 6,9

ST   TPOX: 8,9

ST   vWA: 18,19,20

DI   NCIt; C7558; Endometrial carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A778 ! HOUA-II

SX   Female

CA   Cancer cell line

//

ID   HOUA-II

AC   CVCL_A778

RX   CelloPub=CLPUB00051;

CC   Doubling time: 60 hours (CelloPub=CLPUB00051).

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_3867 ! HOUA-I

SX   Female

CA   Transformed cell line

//

ID   HOUFXXX

AC   CVCL_E957

DR   CLO; CLO_0051368

DR   BioSample; SAMN03472166

DR   RCB; RCB1171

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8,12

ST   D16S539: 10,11

ST   D5S818: 10,12

ST   D7S820: 10

ST   TH01: 7

ST   TPOX: 8,9

ST   vWA: 17

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   HOV

AC   CVCL_0B90

DR   Cosmic; 2239133

RX   PubMed=9559344;

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   HOVTAX2

AC   CVCL_AV53

RX   PubMed=22115851;

WW   http://technologies.ventures.mayoclinic.org/technologies/2010-305_new-cell-lines

ST   Source(s): PubMed=22115851

ST   Amelogenin: X

ST   CSF1PO: 12,13

ST   D13S317: 11,12

ST   D16S539: 13

ST   D18S51: 13,14

ST   D21S11: 30,31

ST   D3S1358: 15

ST   D5S818: 11,12

ST   D7S820: 9,11

ST   D8S1179: 10,13

ST   FGA: 22,23

ST   TPOX: 11

ST   vWA: 14,16

DI   NCIt; C4182; Serous surface papillary carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   HOVTAX2-paclitaxel resistant

AC   CVCL_AV60

RX   PubMed=22115851;

WW   http://technologies.ventures.mayoclinic.org/technologies/2010-305_new-cell-lines

CC   Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).

DI   NCIt; C4182; Serous surface papillary carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_AV53 ! HOVTAX2

SX   Female

CA   Cancer cell line

//

ID   HP

AC   CVCL_3715

SY   HT1080 poly

DR   CLO; CLO_0003797

DR   ATCC; CRL-12012

RX   Patent=US5591624;

CC   Group: Retrovirus packaging cell line.

CC   Characteristics: Heterozygous for the IDH1 p.Arg132Cys mutation.

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 12,14

ST   D16S539: 9,12

ST   D5S818: 11,13

ST   D7S820: 9,10

ST   TH01: 6

ST   TPOX: 8

ST   vWA: 14,19

DI   NCIt; C3043; Fibrosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0317 ! HT-1080

SX   Male

CA   Cancer cell line

//

ID   HP-1

AC   CVCL_C309

DR   Cosmic; 1032369

RX   PubMed=7695406;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   HP-2

AC   CVCL_C310

DR   Cosmic; 1032392

RX   PubMed=7695406;

DI   NCIt; C7985; Epithelioid mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   HP-3

AC   CVCL_C311

DR   Cosmic; 1032377

RX   PubMed=7695406;

DI   NCIt; C7985; Epithelioid mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   HP-A1

AC   CVCL_6G10

RX   PubMed=1318503;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA209].

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_6G11 ! HP-A2

OI   CVCL_6G12 ! HP-W

SX   Female

CA   Transformed cell line

//

ID   HP-A2

AC   CVCL_6G11

RX   PubMed=1318503;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA209].

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_6G10 ! HP-A1

OI   CVCL_6G12 ! HP-W

SX   Female

CA   Transformed cell line

//

ID   Hp-E-1

AC   CVCL_HF43

RX   PubMed=27083164;

CC   Group: Insect cell line.

CC   Doubling time: 136.7 hours (PubMed=27083164).

OX   NCBI_TaxID=93412; ! Holotrichia parallela

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   HP-W

AC   CVCL_6G12

RX   PubMed=1318503;

CC   Transformant: Ad-SV40.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_6G10 ! HP-A1

OI   CVCL_6G11 ! HP-A2

SX   Female

CA   Transformed cell line

//

ID   HP100-1

AC   CVCL_8710

SY   HL60 HP100-1

DR   CLO; CLO_0050987

DR   RCB; RCB0769

RX   PubMed=2796382;

RX   PubMed=9290701;

CC   Selected for resistance to: ChEBI; CHEBI:16240; Hydrogen peroxide.

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 13,14

ST   D13S317: 8,11

ST   D16S539: 11

ST   D5S818: 12

ST   D7S820: 11,12

ST   TH01: 8

ST   TPOX: 8,11

ST   vWA: 16

DI   NCIt; C9154; Adult acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0002 ! HL-60

SX   Female

CA   Cancer cell line

//

ID   HP50-2

AC   CVCL_8711

SY   HL60 HP50-2

DR   CLO; CLO_0050977

DR   RCB; RCB0768

RX   PubMed=2796382;

RX   PubMed=9290701;

CC   Selected for resistance to: ChEBI; CHEBI:16240; Hydrogen peroxide.

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 13,14

ST   D13S317: 8,11

ST   D16S539: 11

ST   D5S818: 12

ST   D7S820: 11,12

ST   TH01: 8

ST   TPOX: 8,11

ST   vWA: 16

DI   NCIt; C9154; Adult acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0002 ! HL-60

SX   Female

CA   Cancer cell line

//

ID   HP6000

AC   CVCL_C481

DR   CLO; CLO_0003798

DR   ATCC; CRL-1754

RX   PubMed=6209201;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   HP6001

AC   CVCL_C482

DR   CLO; CLO_0003799

DR   ATCC; CRL-1755

RX   PubMed=6209201;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   HP6002

AC   CVCL_C483

DR   CLO; CLO_0003800

DR   ATCC; CRL-1788

RX   PubMed=6209201;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   HP6003

AC   CVCL_C484

DR   CLO; CLO_0003801

DR   ATCC; CRL-1756

RX   PubMed=6209201;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   HP6014

AC   CVCL_C485

DR   CLO; CLO_0003802

DR   ATCC; CRL-1752

RX   PubMed=6209201;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   HP6016

AC   CVCL_C486

DR   CLO; CLO_0003803

DR   ATCC; CRL-1787

RX   PubMed=6209201;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   HP6017

AC   CVCL_C487

DR   CLO; CLO_0003804

DR   ATCC; CRL-1753

RX   PubMed=6209201;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   HP6020

AC   CVCL_C488

DR   CLO; CLO_0003805

DR   ATCC; CRL-1789

RX   PubMed=6209201;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   HP6023

AC   CVCL_C489

DR   CLO; CLO_0003806

DR   ATCC; CRL-1776

RX   PubMed=6209201;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   HP6025

AC   CVCL_C490

DR   CLO; CLO_0003807

DR   ATCC; CRL-1775

RX   PubMed=6209201;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   HP6045

AC   CVCL_C491

DR   CLO; CLO_0003808

DR   ATCC; CRL-1757

RX   PubMed=6209201;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   HP6047

AC   CVCL_C492

DR   CLO; CLO_0003809

DR   ATCC; CRL-1774

RX   PubMed=6209201;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   HP6050

AC   CVCL_C493

DR   CLO; CLO_0003810

DR   ATCC; CRL-1768

RX   PubMed=6209201;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   HP6053

AC   CVCL_C494

SY   HP 6053

DR   CLO; CLO_0003811

DR   ATCC; CRL-1758

DR   ECACC; 94050510

RX   PubMed=6209201;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   HP6054

AC   CVCL_C495

SY   HP 6054

DR   CLO; CLO_0003812

DR   ATCC; CRL-1763

DR   ECACC; 93092704

RX   PubMed=6209201;

CC   Discontinued: ECACC; 93092704; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   HP6058

AC   CVCL_C496

DR   CLO; CLO_0003813

DR   ATCC; CRL-1786

RX   PubMed=6209201;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   HP75

AC   CVCL_3516

SY   HP-75

DR   ATCC; CRL-2506

DR   BioSample; SAMN03471601

RX   DOI=10.1007/BF02782609;

RX   PubMed=15541569;

CC   Transformant: Ad5-SV40 (AD-SVR4).

CC   Discontinued: ATCC; CRL-2506; true.

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 8,12

ST   D13S317: 10,11

ST   D16S539: 11,12

ST   D5S818: 10,11

ST   D7S820: 7,8

ST   TH01: 8

ST   TPOX: 10,11

ST   vWA: 17,18

DI   NCIt; C3329; Pituitary gland adenoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   HPA

AC   CVCL_W418

RX   PubMed=6243244;

DI   NCIt; C6242; Oral cavity pleomorphic adenoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   HPa 33

AC   CVCL_Z875

SY   HPa-33; H Pa 33

RX   DOI=10.1016/0022-1910(75)90074-8;

RX   PubMed=4810369;

CC   Group: Insect cell line.

OX   NCBI_TaxID=6978; ! Periplaneta americana

SX   Male

CA   Spontaneously immortalized cell line

//

ID   HPa 34

AC   CVCL_Z876

SY   HPa-34

RX   DOI=10.1016/0022-1910(75)90074-8;

CC   Group: Insect cell line.

OX   NCBI_TaxID=6978; ! Periplaneta americana

SX   Female

CA   Spontaneously immortalized cell line

//

ID   HPAC

AC   CVCL_3517

SY   Hpac

DR   BTO; BTO:0004121

DR   CLO; CLO_0003814

DR   EFO; EFO_0002197

DR   ATCC; CRL-2119

DR   BCRC; 60495

DR   BioSample; SAMN03472247

DR   CCLE; HPAC_PANCREAS

DR   CCRID; 3111C0001CCC000189

DR   ChEMBL-Cells; CHEMBL3308388

DR   ChEMBL-Targets; CHEMBL612595

DR   Cosmic; 913306

DR   Cosmic; 1571784

DR   Cosmic; 1995444

DR   Cosmic; 2434094

DR   Cosmic-CLP; 1298136

DR   GDSC; 1298136

DR   GEO; GSM621897

DR   GEO; GSM206509

DR   GEO; GSM784701

DR   GEO; GSM887089

DR   GEO; GSM888160

DR   GEO; GSM1024401

DR   GEO; GSM1374545

DR   GEO; GSM1669892

DR   IGRhCellID; HPAC

DR   PRIDE; PXD003198

RX   DOI=10.4172/jpb.1000057;

RX   PubMed=20418756;

RX   PubMed=22460905;

RX   PubMed=25167228;

RX   PubMed=25485619;

RX   PubMed=25939163;

RX   PubMed=25984343;

RX   PubMed=27259358;

RX   PubMed=27397505;

WW   http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=HPAC

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: 23 hours (PubMed=25984343).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Proteome analysis by 2D-DE/MS.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 13

ST   D13S317: 11

ST   D16S539: 9,10

ST   D18S51: 16

ST   D21S11: 30

ST   D3S1358: 15,17

ST   D5S818: 12

ST   D7S820: 10,12

ST   D8S1179: 12,14

ST   FGA: 24

ST   Penta D: 13

ST   Penta E: 15,17

ST   TH01: 9.3

ST   TPOX: 10,11

ST   vWA: 15,17

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   HPaC-79

AC   CVCL_M121

SY   HPaC 79; HPaC79

RX   PubMed=3138611;

RX   PubMed=6837290;

DI   NCIt; C5942; Parotid gland squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   HPAE-26

AC   CVCL_3716

SY   WC00107

DR   CLO; CLO_0003815

DR   ATCC; CRL-2598

DR   BioSample; SAMN03471687

DR   Coriell; WC00107

CC   Part of: Wistar Institute Special Collection vascular cell lines.

CC   Discontinued: ATCC; CRL-2598; true.

CC   Discontinued: Coriell; WC00107; probable.

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 11

ST   D16S539: 13,14

ST   D5S818: 12

ST   D7S820: 10

ST   TH01: 7,9.3

ST   TPOX: 8,9

ST   vWA: 17

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0E12 ! HAAE-26

OI   CVCL_3292 ! HIVE-26

OI   CVCL_3718 ! HPVE-26

SX   Male

CA   Finite cell line

//

ID   HPAF

AC   CVCL_B284

SY   HPAF-I

DR   Cosmic; 724640

DR   Cosmic; 736274

DR   Cosmic; 808174

DR   Cosmic; 872999

DR   Cosmic; 922245

DR   Cosmic; 933527

DR   Cosmic; 948376

DR   Cosmic; 948735

RX   PubMed=7034925;

RX   PubMed=11169957;

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   HPAF-II

AC   CVCL_0313

SY   HPAFII; HPAF-2; HPAF2; HPAF/CD18; CD18/HPAF; HPAF-II/CD18; CD-18; CD18; CD 18

DR   BTO; BTO:0003266

DR   CLO; CLO_0003816

DR   EFO; EFO_0002198

DR   GEO; GSM1374546

DR   GEO; GSM1374547

DR   MCCL; MCC:0000206

DR   ATCC; CRL-1997

DR   BioSample; SAMN03471950

DR   CCLE; HPAFII_PANCREAS

DR   CGH-DB; 165-1

DR   CGH-DB; 9274-4

DR   ChEMBL-Cells; CHEMBL3308744

DR   ChEMBL-Targets; CHEMBL1075467

DR   Cosmic; 710858

DR   Cosmic; 724869

DR   Cosmic; 868241

DR   Cosmic; 913304

DR   Cosmic; 922247

DR   Cosmic; 1108343

DR   Cosmic; 1299299

DR   Cosmic; 1320467

DR   Cosmic; 1571777

DR   Cosmic; 2046534

DR   Cosmic; 2434099

DR   Cosmic-CLP; 724869

DR   GDSC; 724869

DR   GEO; GSM206510

DR   GEO; GSM385517

DR   GEO; GSM385528

DR   GEO; GSM621899

DR   GEO; GSM784696

DR   GEO; GSM827289

DR   GEO; GSM887090

DR   GEO; GSM888161

DR   GEO; GSM1024402

DR   GEO; GSM1669893

DR   IGRhCellID; HPAFII

DR   IZSLER; BS TCL 170

DR   PRIDE; PXD003198

DR   TOKU-E; 4028

RX   DOI=10.4172/jpb.1000057;

RX   PubMed=2734279;

RX   PubMed=11787853;

RX   PubMed=12692724;

RX   PubMed=15126341;

RX   PubMed=15367897;

RX   PubMed=18380791;

RX   PubMed=20418756;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=25984343;

RX   PubMed=27259358;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=HPAF-II

WW   http://www.addexbio.com/productdetail?pid=4678

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: KuDOS 95 cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: 70 hours (PubMed=25984343).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Array-based CGH.

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: Proteome analysis by 2D-DE/MS.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Caution: Could not find proof that the CD18 subline of HPAF is really HPAF-II but many indirect evidences points in this direction. If someone read this comment and can help us, please do.

CC   Misspelling: 'HPAF11' in PubMed=25984343.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 12

ST   D16S539: 11,13

ST   D18S51: 13

ST   D21S11: 30,31

ST   D3S1358: 14,18

ST   D5S818: 11,13

ST   D7S820: 10,13

ST   D8S1179: 11,12

ST   FGA: 21,24

ST   Penta D: 9,13

ST   Penta E: 10,13

ST   TH01: 9

ST   TPOX: 8

ST   vWA: 17

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B284 ! HPAF

SX   Male

CA   Cancer cell line

//

ID   HPAF/CD11

AC   CVCL_B285

SY   HPAF-CD11; CD11/HPAF; CD11; CD-11; CD 11

DR   Cosmic; 922246

RX   PubMed=2734279;

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B284 ! HPAF

SX   Male

CA   Cancer cell line

//

ID   HPAF1

AC   CVCL_1Y72

DR   ATCC; CRL-11707

RX   Patent=US5462870;

RX   PubMed=7713331;

CC   Discontinued: ATCC; CRL-11707; probable.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Spontaneously immortalized cell line

//

ID   HPAM1

AC   CVCL_1Y73

DR   EFO; EFO_0006280

DR   ATCC; CRL-11706

RX   Patent=US5462870;

RX   PubMed=7713331;

CC   Discontinued: ATCC; CRL-11706; probable.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Spontaneously immortalized cell line

//

ID   HPB-ALL

AC   CVCL_1820

SY   HPB/ALL; HPBALL; FCCH1018

DR   BTO; BTO:0001952

DR   CLO; CLO_0003817

DR   CLO; CLO_0050988

DR   BioSample; SAMN01821632

DR   BioSample; SAMN03473562

DR   CCLE; HPBALL_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   Cosmic; 801726

DR   Cosmic; 913406

DR   Cosmic; 919159

DR   Cosmic; 933550

DR   Cosmic; 998736

DR   Cosmic; 999754

DR   Cosmic; 1037689

DR   Cosmic; 1115583

DR   Cosmic; 1130235

DR   Cosmic; 1151779

DR   Cosmic; 1224373

DR   Cosmic; 1281368

DR   Cosmic; 1330499

DR   Cosmic; 1524796

DR   Cosmic; 1641378

DR   Cosmic; 1664521

DR   Cosmic; 1760522

DR   Cosmic; 2165711

DR   DSMZ; ACC-483

DR   GEO; GSM887091

DR   GEO; GSM888162

DR   NCBI_Iran; C213

DR   RCB; RCB1935

DR   TKG; TKG 0199

RX   PubMed=203546;

RX   PubMed=1373528;

RX   PubMed=6582512;

RX   PubMed=9738977;

RX   PubMed=9933131;

RX   PubMed=22460905;

RX   PubMed=22675565;

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-55.html

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: ~50 hours (DSMZ).

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): DSMZ; RCB; TKG

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 8,10

ST   D16S539: 9,11

ST   D5S818: 11

ST   D7S820: 11

ST   TH01: 7,9

ST   TPOX: 8,12

ST   vWA: 18,20

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   HPB-MLT

AC   CVCL_7959

SY   FCCH1019

DR   BioSample; SAMN03151780

DR   Cosmic; 721703

DR   Cosmic; 801733

DR   Cosmic; 998731

DR   TKG; TKG 0361

RX   PubMed=203546;

RX   PubMed=1373528;

RX   PubMed=10071127;

RX   PubMed=12592342;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a HPB-ALL derivative (PubMed=12592342, PubMed=20143388).

CC   Misspelling: 'MPB-MLT' in PubMed=10071127.

ST   Source(s): TKG

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 8,10

ST   D16S539: 9,11

ST   D5S818: 11

ST   D7S820: 11

ST   TH01: 7,9

ST   TPOX: 8,12

ST   vWA: 18,20

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1820 ! HPB-ALL

SX   Male

CA   Cancer cell line

//

ID   HPB-Null

AC   CVCL_7960

SY   HPB-NULL; HPB-null; HPB/Null; HPB Null; HPB null

DR   Cosmic; 998711

DR   Cosmic; 999750

DR   Cosmic; 1037727

DR   Cosmic; 2491080

RX   PubMed=9067587;

DI   NCIt; C9143; Adult B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   HPC-1

AC   CVCL_6C64

RX   CelloPub=CLPUB00297;

CC   Doubling time: 26 hours (CelloPub=CLPUB00297).

CC   Derived from metastatic site: Ascites.

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   HPC-1H5

AC   CVCL_6C65

RX   PubMed=12198767;

CC   Derived from metastatic site: Ascites.

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6C64 ! HPC-1

SX   Female

CA   Cancer cell line

//

ID   HPC-1P5

AC   CVCL_6C66

RX   PubMed=12198767;

CC   Derived from metastatic site: Ascites.

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6C64 ! HPC-1

SX   Female

CA   Cancer cell line

//

ID   HPC-3

AC   CVCL_6C67

RX   CelloPub=CLPUB00298;

CC   Doubling time: ~21 hours (CelloPub=CLPUB00298).

CC   Derived from metastatic site: Ascites.

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   HPC-36

AC   CVCL_M169

RX   PubMed=571046;

RX   PubMed=6244232;

RX   PubMed=15643172;

CC   Miscellaneous: Cell line has been lost (PubMed=15643172).

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   HPC-36M

AC   CVCL_8446

SY   HPC36M

DR   BioSample; SAMN03151711

RX   PubMed=10754530;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=20143388). Originally thought to originate from a prostate carcinoma.

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

CC   Caution: Was reported to derive from HPC-36 (CVCL_M169).

ST   Source(s): PubMed=11416159

ST   Amelogenin: X

ST   D18S51: 16

ST   D21S11: 27,28

ST   D8S1179: 12,13

ST   FGA: 18,21

ST   TH01: 7

ST   vWA: 16,18

DI   NCIt; C4029; Cervical adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0030 ! HeLa

SX   Female

CA   Cancer cell line

//

ID   HPC-3H4

AC   CVCL_6C68

RX   PubMed=10385366;

CC   Derived from metastatic site: Ascites.

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6C67 ! HPC-3

SX   Male

CA   Cancer cell line

//

ID   HPC-3P4a

AC   CVCL_6C69

RX   PubMed=11345134;

CC   Derived from metastatic site: Ascites.

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6C67 ! HPC-3

SX   Male

CA   Cancer cell line

//

ID   HPC-4

AC   CVCL_6C70

RX   CelloPub=CLPUB00298;

CC   Doubling time: ~24 hours (CelloPub=CLPUB00298).

CC   Derived from metastatic site: Ascites.

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   HPC-4H4

AC   CVCL_6C71

RX   PubMed=11893931;

CC   Derived from metastatic site: Ascites.

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6C70 ! HPC-4

SX   Male

CA   Cancer cell line

//

ID   HPC-4P4a

AC   CVCL_6C72

RX   PubMed=11893931;

CC   Derived from metastatic site: Ascites.

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6C70 ! HPC-4

SX   Male

CA   Cancer cell line

//

ID   HPC-Y0

AC   CVCL_6912

AS   CVCL_A067

SY   HPC-YO; HPCY0

DR   Cosmic; 730529

RX   PubMed=2208167;

DI   NCIt; C7977; Pancreatic acinar cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   HPC-Y1

AC   CVCL_6913

DR   Cosmic; 730518

RX   PubMed=2208167;

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   HPC-Y11

AC   CVCL_6914

DR   Cosmic; 730521

RX   PubMed=2208167;

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   HPC-Y15

AC   CVCL_6915

RX   PubMed=2208167;

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   HPC-Y19

AC   CVCL_6916

DR   Cosmic; 730522

RX   PubMed=2208167;

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   HPC-Y21

AC   CVCL_A069

DR   Cosmic; 730524

DI   NCIt; C3850; Pancreatic carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   HPC-Y23

AC   CVCL_A068

DR   Cosmic; 730525

DI   NCIt; C3850; Pancreatic carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   HPC-Y25

AC   CVCL_6917

DR   Cosmic; 730526

RX   PubMed=2208167;

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   HPC-Y3

AC   CVCL_A066

DR   Cosmic; 730519

DI   NCIt; C3850; Pancreatic carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   HPC-Y5

AC   CVCL_6918

DR   CCRID; 3142C0001000000502

DR   Cosmic; 730520

RX   PubMed=2208167;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   HPC-Y9

AC   CVCL_6919

RX   PubMed=2208167;

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   HPC-YP

AC   CVCL_6920

RX   PubMed=2208167;

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   HPC-YS

AC   CVCL_6921

RX   PubMed=2208167;

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   HPC-YT

AC   CVCL_A070

DR   Cosmic; 730530

DI   NCIt; C3850; Pancreatic carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   HPC0A07

AC   CVCL_9T02

SY   HPCOA07

RX   Patent=US7666672;

RX   PubMed=18635871;

CC   From: ReNeuron, Ltd.

CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 04092302.

CC   Transfected with: HGNC; 7553; MYC.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Conditionally immortalized cell line

//

ID   HPCT-03-ts

AC   CVCL_9W32

SY   Human Proximal Convoluted Tubule-03-ts

RX   PubMed=14748622;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   HPCT-05-wt

AC   CVCL_9W33

SY   Human Proximal Convoluted Tubule-05-wt

DR   ECACC; 12020703

RX   PubMed=14748622;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

ST   Source(s): ECACC

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 9

ST   D16S539: 11,13

ST   D5S818: 12,13

ST   D7S820: 9,12

ST   TH01: 6,9.3

ST   TPOX: 8,10

ST   vWA: 14,17

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   HPCT-06-wt

AC   CVCL_9W34

SY   Human Proximal Convoluted Tubule-06-wt

RX   PubMed=14748622;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   HPCT-1E3

AC   CVCL_DG56

SY   HPCT 1E3; HPCT clone 1E3

RX   PubMed=7813520;

RX   PubMed=7813521;

RX   PubMed=8738419;

RX   PubMed=24329745;

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_0269 ! Fao

CA   Hybrid cell line

//

ID   HPCT-1F9

AC   CVCL_ER20

SY   HPCT 1F9; HPCT clone 1F9

RX   PubMed=7813520;

RX   PubMed=7813521;

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_0269 ! Fao

CA   Hybrid cell line

//

ID   HPCT-2E9

AC   CVCL_ER21

SY   HPCT 2E9; HPCT clone 2E9

RX   PubMed=7813520;

RX   PubMed=7813521;

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_0269 ! Fao

CA   Hybrid cell line

//

ID   HPD-1NR

AC   CVCL_2072

SY   HPD1NR

DR   CLO; CLO_0003818

DR   DSMZ; ACC-314

DR   TKG; TKG 0722

RX   PubMed=7868943;

CC   Doubling time: ~60-70 hours (DSMZ).

CC   Transformant: ChEBI; CHEBI:131518; N,N-bis(2-hydroxypropyl)nitrosamine (Diisopropanolnitrosamine; DIPN; N-nitrosobis(2-hydroxypropyl)amine).

OX   NCBI_TaxID=10036; ! Mesocricetus auratus

OI   CVCL_2073 ! HPD-2NR

OI   CVCL_T289 ! HPD-3NR

SX   Female

CA   Cancer cell line

//

ID   HPD-2NR

AC   CVCL_2073

SY   HPD2NR

DR   CLO; CLO_0003819

DR   DSMZ; ACC-293

DR   TKG; TKG 0723

RX   PubMed=7868943;

CC   Doubling time: ~40 hours (DSMZ).

CC   Transformant: ChEBI; CHEBI:131518; N,N-bis(2-hydroxypropyl)nitrosamine (Diisopropanolnitrosamine; DIPN; N-nitrosobis(2-hydroxypropyl)amine).

OX   NCBI_TaxID=10036; ! Mesocricetus auratus

OI   CVCL_2072 ! HPD-1NR

OI   CVCL_T289 ! HPD-3NR

SX   Female

CA   Cancer cell line

//

ID   HPD-3NR

AC   CVCL_T289

SY   HPD3NR

DR   TKG; TKG 0724

RX   PubMed=7868943;

CC   Transformant: ChEBI; CHEBI:131518; N,N-bis(2-hydroxypropyl)nitrosamine (Diisopropanolnitrosamine; DIPN; N-nitrosobis(2-hydroxypropyl)amine).

OX   NCBI_TaxID=10036; ! Mesocricetus auratus

OI   CVCL_2072 ! HPD-1NR

OI   CVCL_2073 ! HPD-2NR

SX   Female

CA   Cancer cell line

//

ID   HPDE

AC   CVCL_4376

SY   Human Pancreatic Duct Epithelial

WW   http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=HPDE

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   HPDE-1/E6E7

AC   CVCL_S973

SY   HPDE1/E6E7

RX   PubMed=8669463;

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   HPDE-4/E6E7

AC   CVCL_S974

SY   HPDE4/E6E7; HPDE4

RX   DOI=10.4172/jpb.1000057;

RX   PubMed=8669463;

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].

CC   Omics: Proteome analysis by 2D-DE/MS.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   HPDE-5/E6E7

AC   CVCL_S975

SY   HPDE5/E6E7

RX   PubMed=8669463;

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   HPDE-6/E6E7

AC   CVCL_S972

SY   HPDE6/E6E7; HPDE6-E6E7; HPDE6E6E7

DR   EFO; EFO_0005711

DR   ENCODE; ENCBS224AAA

DR   GEO; GSM621854

DR   GEO; GSM816639

RX   PubMed=11073822;

WW   http://genome.ucsc.edu/encode/protocols/cell/human/HPDE6-E6E7_Crawford_protocol.pdf

CC   Part of: ENCODE project common cell types; tier 3.

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   HPDE6c11

AC   CVCL_0P37

RX   PubMed=11073822;

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_S972 ! HPDE-6/E6E7

SX   Female

CA   Transformed cell line

//

ID   HPDE6c7

AC   CVCL_0P38

SY   H6c7; H6C7

RX   DOI=10.4172/jpb.1000057;

RX   PubMed=11073822;

WW   https://www.kerafast.com/product/2101/human-pancreatic-duct-epithelial-cell-line-h6c7

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].

CC   Omics: Proteome analysis by 2D-DE/MS.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_S972 ! HPDE-6/E6E7

SX   Female

CA   Transformed cell line

//

ID   hPES-1

AC   CVCL_B529

SY   HPES-1; GUCASe001-A

DR   hPSCreg; GUCASe001-A

RX   PubMed=18071366;

CC   From: Graduate University of Chinese Academy of Sciences Institute of Zoology; Beijing; China.

ST   Source(s): PubMed=18071366

ST   Amelogenin: X

ST   CSF1PO: 11,13

ST   D13S317: 10

ST   D18S51: 14,15

ST   D21S11: 30,31

ST   D3S1358: 16

ST   D5S818: 9,11

ST   D7S820: 9,12

ST   D8S1179: 15

ST   FGA: 14,15

ST   Penta D: 11

ST   Penta E: 15,20

ST   TH01: 9

ST   TPOX: 9,11

ST   vWA: 17,19

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   hPES-2

AC   CVCL_B530

SY   HPES-2; GUCASe002-A

DR   hPSCreg; GUCASe002-A

RX   PubMed=18071366;

CC   From: Graduate University of Chinese Academy of Sciences Institute of Zoology; Beijing; China.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   HPET-1

AC   CVCL_EQ24

SY   HPET1; Human Prostate Epithelial/hTERT-1

RX   PubMed=17510410;

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transfected with: HGNC; 11730; TERT.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EQ25 ! HPET-5

OI   CVCL_EQ26 ! HPET-11

OI   CVCL_EQ27 ! HPET-13

SX   Male

CA   Telomerase immortalized cell line

//

ID   HPET-11

AC   CVCL_EQ26

SY   HPET11; Human Prostate Epithelial/hTERT-11

DR   GEO; GSM844559

RX   PubMed=17510410;

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transfected with: HGNC; 11730; TERT.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EQ24 ! HPET-1

OI   CVCL_EQ25 ! HPET-5

OI   CVCL_EQ27 ! HPET-13

SX   Male

CA   Telomerase immortalized cell line

//

ID   HPET-13

AC   CVCL_EQ27

SY   HPET13; Human Prostate Epithelial/hTERT-13

DR   GEO; GSM844560

DR   GEO; GSM844561

RX   PubMed=17510410;

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transfected with: HGNC; 11730; TERT.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EQ24 ! HPET-1

OI   CVCL_EQ25 ! HPET-5

OI   CVCL_EQ26 ! HPET-11

SX   Male

CA   Telomerase immortalized cell line

//

ID   HPET-5

AC   CVCL_EQ25

SY   HPET5; Human Prostate Epithelial/hTERT-5

DR   GEO; GSM844562

RX   PubMed=17510410;

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transfected with: HGNC; 11730; TERT.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EQ24 ! HPET-1

OI   CVCL_EQ26 ! HPET-11

OI   CVCL_EQ27 ! HPET-13

SX   Male

CA   Telomerase immortalized cell line

//

ID   HPK-1A

AC   CVCL_D890

SY   HPK1A; HPK IA; HPKIA

DR   BTO; BTO:0005276

RX   DOI=10.1007/978-1-4612-0411-4_3;

RX   PubMed=1742725;

RX   PubMed=2838778;

RX   PubMed=2556855;

RX   PubMed=21439369;

CC   Characteristics: Contains 2 to 3 copies of the complete HPV16 genomes arranged in a head-to-tail fashion and integrated at a single chromosomal site.

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   HPK-1A-ras

AC   CVCL_D891

SY   HPK-1A/ras; HPK1A-ras; KiMSV/HPK-1A; K-ras/HPK-1A

DR   BTO; BTO:0005275

RX   DOI=10.1007/978-1-4612-0411-4_3;

RX   PubMed=1742725;

RX   PubMed=2556855;

CC   Characteristics: Contains several complete HPV16 genomes arranged in a head-to-tail fashion and integrated at a single chromosomal site.

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).

CC   Transformant: NCBI_TaxID; 11808; Kirsten murine sarcoma virus (Ki-MSV).

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D890 ! HPK-1A

SX   Male

CA   Transformed cell line

//

ID   HPL1A

AC   CVCL_9863

DR   EFO; EFO_0006907

RX   PubMed=9354455;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_9864 ! HPL1B

OI   CVCL_9865 ! HPL1C

OI   CVCL_8880 ! HPL1D

OI   CVCL_9866 ! HPL1E

SX   Female

CA   Transformed cell line

//

ID   HPL1B

AC   CVCL_9864

DR   EFO; EFO_0002705

RX   PubMed=9354455;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_9863 ! HPL1A

OI   CVCL_9865 ! HPL1C

OI   CVCL_8880 ! HPL1D

OI   CVCL_9866 ! HPL1E

SX   Female

CA   Transformed cell line

//

ID   HPL1C

AC   CVCL_9865

DR   EFO; EFO_0006908

RX   PubMed=9354455;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_9863 ! HPL1A

OI   CVCL_9864 ! HPL1B

OI   CVCL_8880 ! HPL1D

OI   CVCL_9866 ! HPL1E

SX   Female

CA   Transformed cell line

//

ID   HPL1D

AC   CVCL_8880

DR   BTO; BTO:0003214

DR   EFO; EFO_0006909

RX   PubMed=9354455;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_9863 ! HPL1A

OI   CVCL_9864 ! HPL1B

OI   CVCL_9865 ! HPL1C

OI   CVCL_9866 ! HPL1E

SX   Female

CA   Transformed cell line

//

ID   HPL1E

AC   CVCL_9866

DR   EFO; EFO_0006910

RX   PubMed=9354455;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_9863 ! HPL1A

OI   CVCL_9864 ! HPL1B

OI   CVCL_9865 ! HPL1C

OI   CVCL_8880 ! HPL1D

SX   Female

CA   Transformed cell line

//

ID   HPLA-A3

AC   CVCL_6G77

RX   PubMed=22687401;

CC   Transfected with: HGNC; 7968; NR1I2.

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

DI   NCIt; C3728; Hepatoblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0027 ! Hep-G2

SX   Male

CA   Cancer cell line

//

ID   HPME

AC   CVCL_3717

DR   CLO; CLO_0003820

DR   ATCC; CRL-6589

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6589; true.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Undefined cell line type

//

ID   HPMEC-ST1.6R

AC   CVCL_8712

RX   PubMed=11742042;

RX   PubMed=12453433;

CC   Transfected with: HGNC; 11730; TERT.

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   hPOB-tert

AC   CVCL_HA41

RX   PubMed=11864909;

CC   Transfected with: HGNC; 11730; TERT.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   Hpr-4

AC   CVCL_4706

DR   CLO; CLO_0051572

DR   RCB; RCB1728

RX   PubMed=8205225;

CC   Selected for resistance to: ChEBI; CHEBI:16240; Hydrogen peroxide.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_2234 ! V79

SX   Male

CA   Spontaneously immortalized cell line

//

ID   HPR600

AC   CVCL_9U05

SY   HPR-600

RX   PubMed=8895552;

RX   PubMed=11414198;

DI   NCIt; C4910; Colon carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   HPRS-1

AC   CVCL_8447

SY   HPRS line 1; MDCC-HP1; HP1

RX   PubMed=69431;

RX   PubMed=4547318;

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9031; ! Gallus gallus

SX   Female

CA   Cancer cell line

//

ID   HPRS-2

AC   CVCL_8448

SY   HPRS line 2; MDCC-HP2; HP2

RX   PubMed=69431;

RX   PubMed=4547318;

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9031; ! Gallus gallus

SX   Female

CA   Cancer cell line

//

ID   HPS0059

AC   CVCL_6C74

DR   RCB; HPS0059

DI   NCIt; C34373; Amyotrophic lateral sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPS0060

AC   CVCL_6C75

DR   RCB; HPS0060

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPS0078

AC   CVCL_T927

DR   RCB; HPS0078

DR   SKIP; SKIP000223

DI   NCIt; C84595; Bernard-Soulier syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0G87 ! HPS0191

CA   Induced pluripotent stem cell

//

ID   HPS0097

AC   CVCL_T964

DR   RCB; HPS0097

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Induced pluripotent stem cell

//

ID   HPS0128

AC   CVCL_Y980

SY   A000005#1

DR   RCB; HPS0128

DR   SKIP; SKIP000031

DI   NCIt; C34373; Amyotrophic lateral sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_T969 ! HPS0129

OI   CVCL_Y518 ! HPS0130

CA   Induced pluripotent stem cell

//

ID   HPS0129

AC   CVCL_T969

SY   A000005#2

DR   RCB; HPS0129

DR   SKIP; SKIP000032

DR   SKIP; SKIP000272

DI   NCIt; C34373; Amyotrophic lateral sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y980 ! HPS0128

OI   CVCL_Y518 ! HPS0130

CA   Induced pluripotent stem cell

//

ID   HPS0130

AC   CVCL_Y518

SY   A000005#7

DR   RCB; HPS0130

DR   SKIP; SKIP000033

DR   SKIP; SKIP000379

DI   NCIt; C34373; Amyotrophic lateral sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y980 ! HPS0128

OI   CVCL_T969 ! HPS0129

CA   Induced pluripotent stem cell

//

ID   HPS0131

AC   CVCL_Y952

SY   A000006#4-2

DR   RCB; HPS0131

DR   SKIP; SKIP000037

DI   NCIt; C118846; Miyoshi muscular dystrophy 1

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y953 ! HPS0132

OI   CVCL_T973 ! HPS0133

CA   Induced pluripotent stem cell

//

ID   HPS0132

AC   CVCL_Y953

SY   A000006#4-3

DR   RCB; HPS0132

DR   SKIP; SKIP000038

DI   NCIt; C118846; Miyoshi muscular dystrophy 1

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y952 ! HPS0131

OI   CVCL_T973 ! HPS0133

CA   Induced pluripotent stem cell

//

ID   HPS0133

AC   CVCL_T973

SY   A000006#6-1

DR   RCB; HPS0133

DR   SKIP; SKIP000039

DR   SKIP; SKIP000273

DI   NCIt; C118846; Miyoshi muscular dystrophy 1

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y952 ! HPS0131

OI   CVCL_Y953 ! HPS0132

CA   Induced pluripotent stem cell

//

ID   HPS0134

AC   CVCL_T970

SY   A000007#5

DR   RCB; HPS0134

DR   SKIP; SKIP000040

DI   NCIt; C34373; Amyotrophic lateral sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y974 ! HPS0135

OI   CVCL_Y975 ! HPS0136

CA   Induced pluripotent stem cell

//

ID   HPS0135

AC   CVCL_Y974

SY   A000007#6

DR   RCB; HPS0135

DR   SKIP; SKIP000041

DI   NCIt; C34373; Amyotrophic lateral sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_T970 ! HPS0134

OI   CVCL_Y975 ! HPS0136

CA   Induced pluripotent stem cell

//

ID   HPS0136

AC   CVCL_Y975

SY   A000007#7

DR   RCB; HPS0136

DR   SKIP; SKIP000042

DI   NCIt; C34373; Amyotrophic lateral sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_T970 ! HPS0134

OI   CVCL_Y974 ! HPS0135

CA   Induced pluripotent stem cell

//

ID   HPS0140

AC   CVCL_T967

SY   A000010#1-8

DR   RCB; HPS0140

DR   SKIP; SKIP000046

DR   SKIP; SKIP000613

DI   NCIt; C34373; Amyotrophic lateral sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y978 ! HPS0141

OI   CVCL_Y979 ! HPS0142

CA   Induced pluripotent stem cell

//

ID   HPS0141

AC   CVCL_Y978

SY   A000010#3-3

DR   RCB; HPS0141

DR   SKIP; SKIP000047

DI   NCIt; C34373; Amyotrophic lateral sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_T967 ! HPS0140

OI   CVCL_Y979 ! HPS0142

CA   Induced pluripotent stem cell

//

ID   HPS0142

AC   CVCL_Y979

SY   A000010#3-4

DR   RCB; HPS0142

DR   SKIP; SKIP000048

DR   SKIP; SKIP000614

DI   NCIt; C34373; Amyotrophic lateral sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_T967 ! HPS0140

OI   CVCL_Y978 ! HPS0141

CA   Induced pluripotent stem cell

//

ID   HPS0143

AC   CVCL_T966

DR   RCB; HPS0143

DR   SKIP; SKIP000274

DI   NCIt; C120046; Congenital fiber-type disproportion

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1Q64 ! HPS0145

CA   Induced pluripotent stem cell

//

ID   HPS0145

AC   CVCL_1Q64

DR   RCB; HPS0145

DR   SKIP; SKIP000624

DI   NCIt; C120046; Congenital fiber-type disproportion

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_T966 ! HPS0143

CA   Induced pluripotent stem cell

//

ID   HPS0146

AC   CVCL_T968

SY   A000023#7

DR   RCB; HPS0146

DR   SKIP; SKIP000052

DR   SKIP; SKIP000275

DI   NCIt; C34373; Amyotrophic lateral sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y976 ! HPS0147

OI   CVCL_Y977 ! HPS0148

CA   Induced pluripotent stem cell

//

ID   HPS0147

AC   CVCL_Y976

SY   A000023#10

DR   RCB; HPS0147

DR   SKIP; SKIP000053

DR   SKIP; SKIP000615

DI   NCIt; C34373; Amyotrophic lateral sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_T968 ! HPS0146

OI   CVCL_Y977 ! HPS0148

CA   Induced pluripotent stem cell

//

ID   HPS0148

AC   CVCL_Y977

SY   A000023#11

DR   RCB; HPS0148

DR   SKIP; SKIP000054

DI   NCIt; C34373; Amyotrophic lateral sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_T968 ! HPS0146

OI   CVCL_Y976 ! HPS0147

CA   Induced pluripotent stem cell

//

ID   HPS0155

AC   CVCL_Y691

SY   A000088#8

DR   RCB; HPS0155

DR   SKIP; SKIP000061

DI   NCIt; C118632; Bardet-Biedl syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_T928 ! HPS0156

OI   CVCL_Y519 ! HPS0157

CA   Induced pluripotent stem cell

//

ID   HPS0156

AC   CVCL_T928

SY   A000088#10

DR   RCB; HPS0156

DR   SKIP; SKIP000062

DR   SKIP; SKIP000264

DI   NCIt; C118632; Bardet-Biedl syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y691 ! HPS0155

OI   CVCL_Y519 ! HPS0157

CA   Induced pluripotent stem cell

//

ID   HPS0157

AC   CVCL_Y519

SY   A000088#12

DR   RCB; HPS0157

DR   SKIP; SKIP000063

DR   SKIP; SKIP000380

DI   NCIt; C118632; Bardet-Biedl syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y691 ! HPS0155

OI   CVCL_T928 ! HPS0156

CA   Induced pluripotent stem cell

//

ID   HPS0164

AC   CVCL_T929

DR   RCB; HPS0164

DR   SKIP; SKIP000245

DI   NCIt; C75482; Duchenne muscular dystrophy

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Induced pluripotent stem cell

//

ID   HPS0169

AC   CVCL_T930

DR   RCB; HPS0169

DR   SKIP; SKIP000244

DI   NCIt; C75482; Duchenne muscular dystrophy

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1Q65 ! HPS0171

CA   Induced pluripotent stem cell

//

ID   HPS0171

AC   CVCL_1Q65

DR   RCB; HPS0171

DI   NCIt; C75482; Duchenne muscular dystrophy

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_T930 ! HPS0169

CA   Induced pluripotent stem cell

//

ID   HPS0172

AC   CVCL_Y919

SY   A000009#2

DR   RCB; HPS0172

DR   SKIP; SKIP000064

DI   NCIt; C26744; Dermatomyositis

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y920 ! HPS0173

OI   CVCL_T931 ! HPS0174

CA   Induced pluripotent stem cell

//

ID   HPS0173

AC   CVCL_Y920

SY   A000009#6

DR   RCB; HPS0173

DR   SKIP; SKIP000065

DI   NCIt; C26744; Dermatomyositis

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y919 ! HPS0172

OI   CVCL_T931 ! HPS0174

CA   Induced pluripotent stem cell

//

ID   HPS0174

AC   CVCL_T931

SY   A000009#7

DR   RCB; HPS0174

DR   SKIP; SKIP000066

DR   SKIP; SKIP000243

DI   NCIt; C26744; Dermatomyositis

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y919 ! HPS0172

OI   CVCL_Y920 ! HPS0173

CA   Induced pluripotent stem cell

//

ID   HPS0175

AC   CVCL_T932

SY   A000027#32-1

DR   RCB; HPS0175

DR   SKIP; SKIP000079

DR   SKIP; SKIP000249

DI   NCIt; C84734; Glycogen storage disease type II

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_T933 ! HPS0176

OI   CVCL_T934 ! HPS0177

CA   Induced pluripotent stem cell

//

ID   HPS0176

AC   CVCL_T933

SY   A000027#33-1

DR   RCB; HPS0176

DR   SKIP; SKIP000080

DR   SKIP; SKIP000250

DI   NCIt; C84734; Glycogen storage disease type II

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_T932 ! HPS0175

OI   CVCL_T934 ! HPS0177

CA   Induced pluripotent stem cell

//

ID   HPS0177

AC   CVCL_T934

SY   A000027#34-2

DR   RCB; HPS0177

DR   SKIP; SKIP000081

DR   SKIP; SKIP000251

DI   NCIt; C84734; Glycogen storage disease type II

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_T932 ! HPS0175

OI   CVCL_T933 ! HPS0176

CA   Induced pluripotent stem cell

//

ID   HPS0178

AC   CVCL_T935

DR   RCB; HPS0178

DR   SKIP; SKIP000242

DI   NCIt; C72070; Systemic scleroderma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_6C76 ! HPS0180

CA   Induced pluripotent stem cell

//

ID   HPS0180

AC   CVCL_6C76

DR   RCB; HPS0180

DI   NCIt; C72070; Systemic scleroderma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_T935 ! HPS0178

CA   Induced pluripotent stem cell

//

ID   HPS0181

AC   CVCL_Y924

SY   A000066#2

DR   RCB; HPS0181

DR   SKIP; SKIP000085

DI   NCIt; C84786; Inclusion body myositis

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y925 ! HPS0182

OI   CVCL_T936 ! HPS0183

CA   Induced pluripotent stem cell

//

ID   HPS0182

AC   CVCL_Y925

SY   A000066#3

DR   RCB; HPS0182

DR   SKIP; SKIP000086

DI   NCIt; C84786; Inclusion body myositis

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y924 ! HPS0181

OI   CVCL_T936 ! HPS0183

CA   Induced pluripotent stem cell

//

ID   HPS0183

AC   CVCL_T936

SY   A000066#5

DR   RCB; HPS0183

DR   SKIP; SKIP000087

DR   SKIP; SKIP000241

DI   NCIt; C84786; Inclusion body myositis

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y924 ! HPS0181

OI   CVCL_Y925 ! HPS0182

CA   Induced pluripotent stem cell

//

ID   HPS0184

AC   CVCL_T937

DR   RCB; HPS0184

DR   SKIP; SKIP000240

DI   NCIt; C72070; Systemic scleroderma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_6C77 ! HPS0185

OI   CVCL_IP64 ! HPS0186

CA   Induced pluripotent stem cell

//

ID   HPS0185

AC   CVCL_6C77

DR   RCB; HPS0185

DI   NCIt; C72070; Systemic scleroderma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_T937 ! HPS0184

OI   CVCL_IP64 ! HPS0186

CA   Induced pluripotent stem cell

//

ID   HPS0186

AC   CVCL_IP64

DR   RCB; HPS0186

DI   NCIt; C72070; Systemic scleroderma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_T937 ! HPS0184

OI   CVCL_6C77 ! HPS0185

CA   Induced pluripotent stem cell

//

ID   HPS0191

AC   CVCL_0G87

DR   RCB; HPS0191

DR   SKIP; SKIP000555

DI   NCIt; C84595; Bernard-Soulier syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_T927 ! HPS0078

CA   Induced pluripotent stem cell

//

ID   HPS0192

AC   CVCL_T971

DR   RCB; HPS0192

DR   SKIP; SKIP000279

DI   NCIt; C79532; Allergic rhinitis

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Induced pluripotent stem cell

//

ID   HPS0207

AC   CVCL_Y522

SY   A000126#1

DR   RCB; HPS0207

DR   SKIP; SKIP000100

DR   SKIP; SKIP000388

DI   NCIt; C118631; Alpha thalassemia X-linked mental retardation syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y968 ! HPS0208

CA   Induced pluripotent stem cell

//

ID   HPS0208

AC   CVCL_Y968

SY   A000126#2

DR   RCB; HPS0208

DR   SKIP; SKIP000101

DI   NCIt; C118631; Alpha thalassemia X-linked mental retardation syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y522 ! HPS0207

CA   Induced pluripotent stem cell

//

ID   HPS0209

AC   CVCL_T974

SY   A000145#3-1

DR   RCB; HPS0209

DR   SKIP; SKIP000102

DR   SKIP; SKIP000280

DI   NCIt; C3120; Pulmonary hypertension

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y933 ! HPS0210

OI   CVCL_Y934 ! HPS0211

CA   Induced pluripotent stem cell

//

ID   HPS0210

AC   CVCL_Y933

SY   A000145#3-2

DR   RCB; HPS0210

DR   SKIP; SKIP000103

DI   NCIt; C3120; Pulmonary hypertension

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_T974 ! HPS0209

OI   CVCL_Y934 ! HPS0211

CA   Induced pluripotent stem cell

//

ID   HPS0211

AC   CVCL_Y934

SY   A000145#3-4

DR   RCB; HPS0211

DR   SKIP; SKIP000104

DI   NCIt; C3120; Pulmonary hypertension

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_T974 ! HPS0209

OI   CVCL_Y933 ! HPS0210

CA   Induced pluripotent stem cell

//

ID   HPS0214

AC   CVCL_T938

DR   RCB; HPS0214

DR   SKIP; SKIP000239

DI   NCIt; C34568; Ehlers-Danlos syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Induced pluripotent stem cell

//

ID   HPS0215

AC   CVCL_T972

DR   RCB; HPS0215

DR   SKIP; SKIP000281

DI   NCIt; C84895; Moyamoya disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_IP65 ! HPS0217

CA   Induced pluripotent stem cell

//

ID   HPS0217

AC   CVCL_IP65

DR   RCB; HPS0217

DI   NCIt; C84895; Moyamoya disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_T972 ! HPS0215

CA   Induced pluripotent stem cell

//

ID   HPS0224

AC   CVCL_T939

SY   A000002#2-1

DR   RCB; HPS0224

DR   SKIP; SKIP000111

DR   SKIP; SKIP000238

DI   NCIt; C84554; Familial amyloid neuropathy

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y972 ! HPS0225

OI   CVCL_Y973 ! HPS0226

CA   Induced pluripotent stem cell

//

ID   HPS0225

AC   CVCL_Y972

SY   A000002#2-2

DR   RCB; HPS0225

DR   SKIP; SKIP000112

DI   NCIt; C84554; Familial amyloid neuropathy

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_T939 ! HPS0224

OI   CVCL_Y973 ! HPS0226

CA   Induced pluripotent stem cell

//

ID   HPS0226

AC   CVCL_Y973

SY   A000002#2-5

DR   RCB; HPS0226

DR   SKIP; SKIP000113

DI   NCIt; C84554; Familial amyloid neuropathy

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_T939 ! HPS0224

OI   CVCL_Y972 ! HPS0225

CA   Induced pluripotent stem cell

//

ID   HPS0227

AC   CVCL_Y516

SY   A000003#3-6

DR   RCB; HPS0227

DR   SKIP; SKIP000114

DR   SKIP; SKIP000389

DI   NCIt; C84554; Familial amyloid neuropathy

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y971 ! HPS0228

CA   Induced pluripotent stem cell

//

ID   HPS0228

AC   CVCL_Y971

DR   RCB; HPS0228

DR   SKIP; SKIP000115

DI   NCIt; C84554; Familial amyloid neuropathy

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y516 ! HPS0227

CA   Induced pluripotent stem cell

//

ID   HPS0232

AC   CVCL_Y929

SY   A000018#18-12-2

DR   RCB; HPS0232

DR   SKIP; SKIP000119

DI   NCIt; C84587; Becker's muscular dystrophy

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y520 ! HPS0233

OI   CVCL_Y931 ! HPS0234

CA   Induced pluripotent stem cell

//

ID   HPS0233

AC   CVCL_Y520

SY   A000018#18-12-25

DR   RCB; HPS0233

DR   SKIP; SKIP000120

DR   SKIP; SKIP000381

DI   NCIt; C84587; Becker's muscular dystrophy

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y929 ! HPS0232

OI   CVCL_Y931 ! HPS0234

CA   Induced pluripotent stem cell

//

ID   HPS0234

AC   CVCL_Y931

SY   A000018#18-15-8

DR   RCB; HPS0234

DR   SKIP; SKIP000121

DI   NCIt; C84587; Becker's muscular dystrophy

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y929 ! HPS0232

OI   CVCL_Y520 ! HPS0233

CA   Induced pluripotent stem cell

//

ID   HPS0244

AC   CVCL_Y521

SY   A000196#1

DR   RCB; HPS0244

DR   SKIP; SKIP000131

DR   SKIP; SKIP000382

DI   NCIt; C118631; Alpha thalassemia X-linked mental retardation syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y969 ! HPS0245

OI   CVCL_Y970 ! HPS0246

CA   Induced pluripotent stem cell

//

ID   HPS0245

AC   CVCL_Y969

SY   A000196#5

DR   RCB; HPS0245

DR   SKIP; SKIP000132

DI   NCIt; C118631; Alpha thalassemia X-linked mental retardation syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y521 ! HPS0244

OI   CVCL_Y970 ! HPS0246

CA   Induced pluripotent stem cell

//

ID   HPS0246

AC   CVCL_Y970

SY   A000196#6

DR   RCB; HPS0246

DR   SKIP; SKIP000133

DI   NCIt; C118631; Alpha thalassemia X-linked mental retardation syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_Y521 ! HPS0244

OI   CVCL_Y969 ! HPS0245

CA   Induced pluripotent stem cell

//

ID   HPS0247

AC   CVCL_6C78

DR   RCB; HPS0247

DI   NCIt; C34373; Amyotrophic lateral sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Induced pluripotent stem cell

//

ID   HPS0248

AC   CVCL_6C79

DR   RCB; HPS0248

DI   NCIt; C34373; Amyotrophic lateral sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Induced pluripotent stem cell

//

ID   HPS0249

AC   CVCL_6C80

DR   RCB; HPS0249

DI   NCIt; C34373; Amyotrophic lateral sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Induced pluripotent stem cell

//

ID   HPS0254

AC   CVCL_6C81

DR   RCB; HPS0254

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Induced pluripotent stem cell

//

ID   HPS0255

AC   CVCL_6C82

DR   RCB; HPS0255

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Induced pluripotent stem cell

//

ID   HPS0256

AC   CVCL_6C83

DR   RCB; HPS0256

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Induced pluripotent stem cell

//

ID   HPS0263

AC   CVCL_6C84

DR   RCB; HPS0263

DI   NCIt; C82342; Huntington's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Induced pluripotent stem cell

//

ID   HPS0264

AC   CVCL_T944

DR   RCB; HPS0264

DR   SKIP; SKIP000265

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Induced pluripotent stem cell

//

ID   HPS0265

AC   CVCL_T940

DR   RCB; HPS0265

DR   SKIP; SKIP000237

DI   NCIt; C3962; Adenosine deaminase deficiency

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_6C85 ! HPS0266

CA   Induced pluripotent stem cell

//

ID   HPS0266

AC   CVCL_6C85

DR   RCB; HPS0266

DI   NCIt; C3962; Adenosine deaminase deficiency

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_T940 ! HPS0265

CA   Induced pluripotent stem cell

//

ID   HPS0270

AC   CVCL_T941

DR   RCB; HPS0270

DR   SKIP; SKIP000235

DI   NCIt; C3001; Eczema

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_T942 ! HPS0271

OI   CVCL_T943 ! HPS0272

CA   Induced pluripotent stem cell

//

ID   HPS0271

AC   CVCL_T942

DR   RCB; HPS0271

DR   SKIP; SKIP000236

DI   NCIt; C3001; Eczema

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_T941 ! HPS0270

OI   CVCL_T943 ! HPS0272

CA   Induced pluripotent stem cell

//

ID   HPS0272

AC   CVCL_T943

DR   RCB; HPS0272

DR   SKIP; SKIP000282

DI   NCIt; C3001; Eczema

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_T941 ! HPS0270

OI   CVCL_T942 ! HPS0271

CA   Induced pluripotent stem cell

//

ID   HPS0312

AC   CVCL_6C86

DR   RCB; HPS0312

DI   NCIt; C75482; Duchenne muscular dystrophy

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Induced pluripotent stem cell

//

ID   HPS0317

AC   CVCL_1Q66

DR   RCB; HPS0317

DR   SKIP; SKIP000618

DI   NCIt; C75482; Duchenne muscular dystrophy

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1Q67 ! HPS0322

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPS0322

AC   CVCL_1Q67

DR   RCB; HPS0322

DR   SKIP; SKIP000619

DI   NCIt; C75482; Duchenne muscular dystrophy

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1Q66 ! HPS0317

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPS0332

AC   CVCL_1R58

DR   RCB; HPS0332

DR   SKIP; SKIP000627

DI   NCIt; C26798; Hypophosphatasia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1R59 ! HPS0333

CA   Induced pluripotent stem cell

//

ID   HPS0333

AC   CVCL_1R59

DR   RCB; HPS0333

DR   SKIP; SKIP000628

DI   NCIt; C26798; Hypophosphatasia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1R58 ! HPS0332

CA   Induced pluripotent stem cell

//

ID   HPS0334

AC   CVCL_1R65

DR   RCB; HPS0334

DR   SKIP; SKIP000629

DI   NCIt; C26788; Chronic granulomatous disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1R66 ! HPS0335

OI   CVCL_1R67 ! HPS0336

CA   Induced pluripotent stem cell

//

ID   HPS0335

AC   CVCL_1R66

DR   RCB; HPS0335

DR   SKIP; SKIP000630

DI   NCIt; C26788; Chronic granulomatous disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1R65 ! HPS0334

OI   CVCL_1R67 ! HPS0336

CA   Induced pluripotent stem cell

//

ID   HPS0336

AC   CVCL_1R67

DR   RCB; HPS0336

DR   SKIP; SKIP000631

DI   NCIt; C26788; Chronic granulomatous disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1R65 ! HPS0334

OI   CVCL_1R66 ! HPS0335

CA   Induced pluripotent stem cell

//

ID   HPS0337

AC   CVCL_1T00

DR   RCB; HPS0337

DR   SKIP; SKIP000632

DI   NCIt; C26788; Chronic granulomatous disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1T01 ! HPS0338

OI   CVCL_1T02 ! HPS0339

CA   Induced pluripotent stem cell

//

ID   HPS0338

AC   CVCL_1T01

DR   RCB; HPS0338

DR   SKIP; SKIP000633

DI   NCIt; C26788; Chronic granulomatous disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1T00 ! HPS0337

OI   CVCL_1T02 ! HPS0339

CA   Induced pluripotent stem cell

//

ID   HPS0339

AC   CVCL_1T02

DR   RCB; HPS0339

DR   SKIP; SKIP000634

DI   NCIt; C26788; Chronic granulomatous disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1T00 ! HPS0337

OI   CVCL_1T01 ! HPS0338

CA   Induced pluripotent stem cell

//

ID   HPS0414

AC   CVCL_IP66

DR   RCB; HPS0414

DI   NCIt; C129933; Primary lateral sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Induced pluripotent stem cell

//

ID   hPSC-1

AC   CVCL_T767

DR   RCB; RCB3586

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   hPSC-14

AC   CVCL_T768

DR   RCB; RCB3589

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   hPSC-5

AC   CVCL_T769

DR   RCB; RCB3588

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   HPSI0114i-bezi_1

AC   CVCL_AE24

SY   WTSIi041-A

DR   BioSamples; SAMEA2518325

DR   EBiSC; WTSIi041-A

DR   ECACC; 66540037

DR   ECACC; 77650042

DR   HipSci; HPSI0114i-bezi_1

DR   hPSCreg; WTSIi041-A

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE25 ! HPSI0114i-bezi_3

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0114i-bezi_3

AC   CVCL_AE25

DR   ECACC; 77650041

DR   HipSci; HPSI0114i-bezi_3

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE24 ! HPSI0114i-bezi_1

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0114i-eipl_1

AC   CVCL_AE06

SY   WTSIi020-A

DR   BioSamples; SAMEA2536417

DR   EBiSC; WTSIi020-A

DR   ECACC; 66540090

DR   ECACC; 77650081

DR   HipSci; HPSI0114i-eipl_1

DR   hPSCreg; WTSIi020-A

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Genome sequenced.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE21 ! HPSI0114i-eipl_3

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0114i-eipl_3

AC   CVCL_AE21

SY   WTSIi020-B

DR   BioSamples; SAMEA2536405

DR   EBiSC; WTSIi020-B

DR   ECACC; 66540239

DR   ECACC; 77650198

DR   HipSci; HPSI0114i-eipl_3

DR   hPSCreg; WTSIi020-B

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE06 ! HPSI0114i-eipl_1

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0114i-fikt_2

AC   CVCL_AE26

DR   HipSci; HPSI0114i-fikt_2

CC   From: Cambridge BioResource; Cambridge; UK.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE27 ! HPSI0114i-fikt_3

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0114i-fikt_3

AC   CVCL_AE27

SY   WTSIi072-A

DR   BioSamples; SAMEA2547619

DR   EBiSC; WTSIi072-A

DR   ECACC; 66540184

DR   ECACC; 77650106

DR   HipSci; HPSI0114i-fikt_3

DR   hPSCreg; WTSIi072-A

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE26 ! HPSI0114i-fikt_2

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0114i-iisa_1

AC   CVCL_AE22

SY   WTSIi019-B

DR   BioSamples; SAMEA2536412

DR   EBiSC; WTSIi019-B

DR   ECACC; 66540129

DR   ECACC; 77650096

DR   HipSci; HPSI0114i-iisa_1

DR   hPSCreg; WTSIi019-B

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE05 ! HPSI0114i-iisa_3

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0114i-iisa_3

AC   CVCL_AE05

SY   WTSIi019-A

DR   BioSamples; SAMEA2536410

DR   EBiSC; WTSIi019-A

DR   ECACC; 66540089

DR   ECACC; 77650082

DR   HipSci; HPSI0114i-iisa_3

DR   hPSCreg; WTSIi019-A

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE22 ! HPSI0114i-iisa_1

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0114i-joxm_1

AC   CVCL_AE28

SY   WTSIi074-A

DR   BioSamples; SAMEA2547637

DR   EBiSC; WTSIi074-A

DR   ECACC; 66540186

DR   ECACC; 77650047

DR   HipSci; HPSI0114i-joxm_1

DR   hPSCreg; WTSIi074-A

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0114i-kolf_2

AC   CVCL_AE29

SY   WTSIi018-B

DR   BioSamples; SAMEA2547615

DR   ECACC; 77650100

DR   HipSci; HPSI0114i-kolf_2

DR   hPSCreg; WTSIi018-B

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE30 ! HPSI0114i-kolf_3

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0114i-Kolf_2-C1

AC   CVCL_9S58

SY   WTSIi018-B-1

DR   hPSCreg; WTSIi018-B-1

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_AE29 ! HPSI0114i-kolf_2

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0114i-kolf_3

AC   CVCL_AE30

SY   WTSIi018-A

DR   BioSamples; SAMEA2547644

DR   EBiSC; WTSIi018-A

DR   ECACC; 66540088

DR   ECACC; 77650048

DR   HipSci; HPSI0114i-kolf_3

DR   hPSCreg; WTSIi018-A

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE29 ! HPSI0114i-kolf_2

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0114i-lexy_1

AC   CVCL_AE31

SY   WTSIi017-B

DR   BioSamples; SAMEA2536416

DR   EBiSC; WTSIi017-B

DR   ECACC; 66540187

DR   ECACC; 77650054

DR   HipSci; HPSI0114i-lexy_1

DR   hPSCreg; WTSIi017-B

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE32 ! HPSI0114i-lexy_2

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0114i-lexy_2

AC   CVCL_AE32

SY   WTSIi017-A

DR   BioSamples; SAMEA2536404

DR   EBiSC; WTSIi017-A

DR   ECACC; 66540087

DR   HipSci; HPSI0114i-lexy_2

DR   hPSCreg; WTSIi017-A

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE31 ! HPSI0114i-lexy_1

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0114i-oevr_3

AC   CVCL_AE04

SY   WTSIi016-A

DR   BioSamples; SAMEA2570435

DR   EBiSC; WTSIi016-A

DR   ECACC; 66540086

DR   ECACC; 77650072

DR   HipSci; HPSI0114i-oevr_3

DR   hPSCreg; WTSIi016-A

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0114i-rozh_4

AC   CVCL_AE33

SY   WTSIi015-B

DR   BioSamples; SAMEA2555017

DR   EBiSC; WTSIi015-B

DR   ECACC; 66540113

DR   ECACC; 77650050

DR   HipSci; HPSI0114i-rozh_4

DR   hPSCreg; WTSIi015-B

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE34 ! HPSI0114i-rozh_5

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0114i-rozh_5

AC   CVCL_AE34

SY   WTSIi015-A

DR   BioSamples; SAMEA2555012

DR   EBiSC; WTSIi015-A

DR   ECACC; 66540085

DR   ECACC; 77650043

DR   HipSci; HPSI0114i-rozh_5

DR   hPSCreg; WTSIi015-A

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE33 ! HPSI0114i-rozh_4

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0114i-vabj_3

AC   CVCL_AE35

SY   WTSIi024-A

DR   BioSamples; SAMEA2595426

DR   EBiSC; WTSIi024-A

DR   ECACC; 66540094

DR   ECACC; 77650053

DR   HipSci; HPSI0114i-vabj_3

DR   hPSCreg; WTSIi024-A

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0114i-vass_1

AC   CVCL_AE36

SY   WTSIi075-A

DR   BioSamples; SAMEA2627141

DR   EBiSC; WTSIi075-A

DR   ECACC; 66540188

DR   ECACC; 77650044

DR   HipSci; HPSI0114i-vass_1

DR   hPSCreg; WTSIi075-A

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0114i-veui_3

AC   CVCL_AE37

SY   WTSIi148-A

DR   BioSamples; SAMEA2464772

DR   ECACC; 77650267

DR   HipSci; HPSI0114i-veui_3

DR   hPSCreg; WTSIi143-A

CC   From: University College London; London; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

DI   NCIt; C118632; Bardet-Biedl syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0114i-wegi_1

AC   CVCL_AE38

SY   WTSIi144-A

DR   BioSamples; SAMEA2547631

DR   EBiSC; WTSIi144-A

DR   ECACC; 66540254

DR   ECACC; 77650197

DR   HipSci; HPSI0114i-wegi_1

DR   hPSCreg; WTSIi144-A

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0114i-zapk_2

AC   CVCL_AE39

SY   WTSIi023-B

DR   BioSamples; SAMEA2570426

DR   EBiSC; WTSIi023-B

DR   ECACC; 66540261

DR   ECACC; 77650195

DR   HipSci; HPSI0114i-zapk_2

DR   hPSCreg; WTSIi023-B

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE40 ! HPSI0114i-zapk_3

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0114i-zapk_3

AC   CVCL_AE40

SY   WTSIi023-A

DR   BioSamples; SAMEA2570432

DR   EBiSC; WTSIi023-A

DR   ECACC; 66540093

DR   ECACC; 77650156

DR   HipSci; HPSI0114i-zapk_3

DR   hPSCreg; WTSIi023-A

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE39 ! HPSI0114i-zapk_2

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0114i-zoxy_3

AC   CVCL_AE41

SY   WTSIi037-A

DR   BioSamples; SAMEA2536413

DR   ECACC; 77650164

DR   HipSci; HPSI0114i-zoxy_3

DR   hPSCreg; WTSIi037-A

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0115i-aion_2

AC   CVCL_EE75

DR   HipSci; HPSI0115i-aion_2

CC   From: Cambridge BioResource; Cambridge; UK.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EE76 ! HPSI0115i-aion_3

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0115i-aion_3

AC   CVCL_EE76

DR   HipSci; HPSI0115i-aion_3

CC   From: Cambridge BioResource; Cambridge; UK.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EE75 ! HPSI0115i-aion_2

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0115i-gifk_1

AC   CVCL_AJ81

DR   HipSci; HPSI0115i-gifk_1

CC   From: Cambridge BioResource; Cambridge; UK.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0115i-hecn_3

AC   CVCL_EE77

DR   HipSci; HPSI0115i-hecn_3

CC   From: Cambridge BioResource; Cambridge; UK.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EE78 ! HPSI0115i-hecn_6

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0115i-hecn_6

AC   CVCL_EE78

DR   HipSci; HPSI0115i-hecn_6

CC   From: Cambridge BioResource; Cambridge; UK.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EE77 ! HPSI0115i-hecn_3

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0115i-iiyk_2

AC   CVCL_EE79

DR   HipSci; HPSI0115i-iiyk_2

CC   From: Cambridge BioResource; Cambridge; UK.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EE80 ! HPSI0115i-iiyk_4

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0115i-iiyk_4

AC   CVCL_EE80

DR   HipSci; HPSI0115i-iiyk_4

CC   From: Cambridge BioResource; Cambridge; UK.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EE79 ! HPSI0115i-iiyk_2

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0115i-melw_1

AC   CVCL_AJ82

DR   HipSci; HPSI0115i-melw_1

CC   From: Cambridge BioResource; Cambridge; UK.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AJ83 ! HPSI0115i-melw_2

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0115i-melw_2

AC   CVCL_AJ83

DR   HipSci; HPSI0115i-melw_2

CC   From: Cambridge BioResource; Cambridge; UK.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AJ82 ! HPSI0115i-melw_1

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0115i-qoog_4

AC   CVCL_EE81

DR   HipSci; HPSI0115i-qoog_4

CC   From: Cambridge BioResource; Cambridge; UK.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EE82 ! HPSI0115i-qoog_6

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0115i-qoog_6

AC   CVCL_EE82

DR   HipSci; HPSI0115i-qoog_6

CC   From: Cambridge BioResource; Cambridge; UK.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EE81 ! HPSI0115i-qoog_4

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0115i-uolo_5

AC   CVCL_AE42

DR   HipSci; HPSI0115i-uolo_5

CC   From: Cambridge BioResource; Cambridge; UK.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0115i-vazt_1

AC   CVCL_EE83

DR   HipSci; HPSI0115i-vazt_1

CC   From: Cambridge BioResource; Cambridge; UK.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EE84 ! HPSI0115i-vazt_2

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0115i-vazt_2

AC   CVCL_EE84

DR   HipSci; HPSI0115i-vazt_2

CC   From: Cambridge BioResource; Cambridge; UK.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EE83 ! HPSI0115i-vazt_1

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0115i-zihe_1

AC   CVCL_AJ84

DR   HipSci; HPSI0115i-zihe_1

CC   From: Cambridge BioResource; Cambridge; UK.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0213i-koun_2

AC   CVCL_AE43

DR   HipSci; HPSI0213i-koun_2

CC   From: Cambridge BioResource; Cambridge; UK.

CC   Omics: Cellular phenotyping.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE44 ! HPSI0213i-koun_4

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0213i-koun_4

AC   CVCL_AE44

DR   HipSci; HPSI0213i-koun_4

CC   From: Cambridge BioResource; Cambridge; UK.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE43 ! HPSI0213i-koun_2

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0213i-nawk_5

AC   CVCL_AE45

DR   HipSci; HPSI0213i-nawk_5

CC   From: Cambridge BioResource; Cambridge; UK.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE46 ! HPSI0213i-nawk_55

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0213i-nawk_55

AC   CVCL_AE46

DR   HipSci; HPSI0213i-nawk_55

CC   From: Cambridge BioResource; Cambridge; UK.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE45 ! HPSI0213i-nawk_5

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0213i-xeaw_1

AC   CVCL_AE47

DR   HipSci; HPSI0213i-xeaw_1

CC   From: Cambridge BioResource; Cambridge; UK.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0214i-bute_2

AC   CVCL_AE48

DR   HipSci; HPSI0214i-bute_2

CC   From: Cambridge BioResource; Cambridge; UK.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0214i-datg_2

AC   CVCL_AE49

SY   WTSIi048-A

DR   BioSamples; SAMEA2632921

DR   EBiSC; WTSIi048-A

DR   ECACC; 66540127

DR   ECACC; 77650205

DR   HipSci; HPSI0214i-datg_2

DR   hPSCreg; WTSIi048-A

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0214i-eiwy_1

AC   CVCL_AE50

SY   WTSIi044-A

DR   BioSamples; SAMEA2645805

DR   EBiSC; WTSIi044-A

DR   ECACC; 66540118

DR   ECACC; 77650165

DR   HipSci; HPSI0214i-eiwy_1

DR   hPSCreg; WTSIi044-A

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0214i-feec_2

AC   CVCL_AE51

SY   WTSIi135-A

DR   BioSamples; SAMEA2612471

DR   EBiSC; WTSIi135-A

DR   ECACC; 66540240

DR   ECACC; 77650191

DR   HipSci; HPSI0214i-feec_2

DR   hPSCreg; WTSIi135-A

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE52 ! HPSI0214i-feec_3

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0214i-feec_3

AC   CVCL_AE52

DR   HipSci; HPSI0214i-feec_3

CC   From: Cambridge BioResource; Cambridge; UK.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE51 ! HPSI0214i-feec_2

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0214i-fiau_1

AC   CVCL_AE53

DR   HipSci; HPSI0214i-fiau_1

CC   From: Cambridge BioResource; Cambridge; UK.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0214i-giju_2

AC   CVCL_AE54

DR   HipSci; HPSI0214i-giju_2

CC   From: Cambridge BioResource; Cambridge; UK.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE55 ! HPSI0214i-giju_3

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0214i-giju_3

AC   CVCL_AE55

DR   HipSci; HPSI0214i-giju_3

CC   From: Cambridge BioResource; Cambridge; UK.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE54 ! HPSI0214i-giju_2

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0214i-heja_1

AC   CVCL_AE56

SY   WTSIi014-B

DR   BioSamples; SAMEA2627577

DR   EBiSC; WTSIi014-B

DR   ECACC; 66540112

DR   ECACC; 77650124

DR   HipSci; HPSI0214i-heja_1

DR   hPSCreg; WTSIi014-B

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE57 ! HPSI0214i-heja_2

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0214i-heja_2

AC   CVCL_AE57

SY   WTSIi014-A

DR   BioSamples; SAMEA2627578

DR   EBiSC; WTSIi014-A

DR   ECACC; 66540084

DR   ECACC; 77650085

DR   HipSci; HPSI0214i-heja_2

DR   hPSCreg; WTSIi014-A

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE56 ! HPSI0214i-heja_1

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0214i-heth_1

AC   CVCL_AE58

SY   WTSIi045-A

DR   BioSamples; SAMEA2658090

DR   EBiSC; WTSIi045-A

DR   ECACC; 66540119

DR   ECACC; 77650139

DR   HipSci; HPSI0214i-heth_1

DR   hPSCreg; WTSIi045-A

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0214i-kehc_2

AC   CVCL_AE59

SY   WTSIi076-A

DR   BioSamples; SAMEA2658107

DR   EBiSC; WTSIi076-A

DR   ECACC; 66540189

DR   ECACC; 77650052

DR   HipSci; HPSI0214i-kehc_2

DR   hPSCreg; WTSIi076-A

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0214i-kucg_2

AC   CVCL_AE60

SY   WTSIi013-A

DR   BioSamples; SAMEA2645814

DR   EBiSC; WTSIi013-A

DR   ECACC; 66540083

DR   ECACC; 77650065

DR   HipSci; HPSI0214i-kucg_2

DR   hPSCreg; WTSIi013-A

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0214i-pelm_1

AC   CVCL_AE61

SY   WTSIi030-B

DR   BioSamples; SAMEA2678742

DR   EBiSC; WTSIi030-B

DR   ECACC; 66540128

DR   ECACC; 77650089

DR   HipSci; HPSI0214i-pelm_1

DR   hPSCreg; WTSIi030-B

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE62 ! HPSI0214i-pelm_3

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0214i-pelm_3

AC   CVCL_AE62

SY   WTSIi030-A

DR   BioSamples; SAMEA2678738

DR   EBiSC; WTSIi030-A

DR   ECACC; 66540100

DR   ECACC; 77650070

DR   HipSci; HPSI0214i-pelm_3

DR   hPSCreg; WTSIi030-A

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE61 ! HPSI0214i-pelm_1

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0214i-poih_2

AC   CVCL_EE42

SY   WTSIi168-B

DR   BioSamples; SAMEA3968761

DR   ECACC; 77650304

DR   HipSci; HPSI0214i-poih_2

DR   hPSCreg; WTSIi168-B

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EE43 ! HPSI0214i-poih_4

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0214i-poih_4

AC   CVCL_EE43

SY   WTSIi168-A

DR   BioSamples; SAMEA3969686

DR   EBiSC; WTSIi168-A

DR   ECACC; 66540336

DR   ECACC; 77650305

DR   HipSci; HPSI0214i-poih_4

DR   hPSCreg; WTSIi168-A

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EE42 ! HPSI0214i-poih_2

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0214i-rayr_1

AC   CVCL_AE63

SY   WTSIi143-A

DR   BioSamples; SAMEA2649534

DR   EBiSC; WTSIi143-A

DR   ECACC; 66540252

DR   ECACC; 77650196

DR   HipSci; HPSI0214i-rayr_1

DR   hPSCreg; WTSIi143-A

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0214i-wibj_1

AC   CVCL_AE64

SY   WTSIi046-B

DR   BioSamples; SAMEA2627566

DR   EBiSC; WTSIi046-B

DR   ECACC; 66540255

DR   ECACC; 77650257

DR   HipSci; HPSI0214i-wibj_1

DR   hPSCreg; WTSIi046-B

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE65 ! HPSI0214i-wibj_2

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0214i-wibj_2

AC   CVCL_AE65

SY   WTSIi046-A

DR   BioSamples; SAMEA2627567

DR   EBiSC; WTSIi046-A

DR   ECACC; 66540120

DR   ECACC; 77650057

DR   HipSci; HPSI0214i-wibj_2

DR   hPSCreg; WTSIi046-A

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE64 ! HPSI0214i-wibj_1

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0215i-deyz_2

AC   CVCL_AJ85

DR   HipSci; HPSI0215i-deyz_2

CC   From: Cambridge BioResource; Cambridge; UK.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AJ86 ! HPSI0215i-deyz_3

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0215i-deyz_3

AC   CVCL_AJ86

DR   HipSci; HPSI0215i-deyz_3

CC   From: Cambridge BioResource; Cambridge; UK.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AJ85 ! HPSI0215i-deyz_2

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0215i-fawm_2

AC   CVCL_EE55

SY   WTSIi178-A

DR   BioSamples; SAMEA3735541

DR   EBiSC; WTSIi178-A

DR   ECACC; 66540350

DR   ECACC; 77650288

DR   HipSci; HPSI0215i-fawm_2

DR   hPSCreg; WTSIi178-A

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EE56 ! HPSI0215i-fawm_4

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0215i-fawm_4

AC   CVCL_EE56

SY   WTSIi178-B

DR   BioSamples; SAMEA3754916

DR   EBiSC; WTSIi178-B

DR   ECACC; 66540351

DR   HipSci; HPSI0215i-fawm_4

DR   hPSCreg; WTSIi178-B

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EE55 ! HPSI0215i-fawm_2

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0215i-hipn_1

AC   CVCL_AE66

DR   HipSci; HPSI0215i-hipn_1

CC   From: Cambridge BioResource; Cambridge; UK.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE67 ! HPSI0215i-hipn_2

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0215i-hipn_2

AC   CVCL_AE67

DR   HipSci; HPSI0215i-hipn_2

CC   From: Cambridge BioResource; Cambridge; UK.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE66 ! HPSI0215i-hipn_1

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0215i-oilg_1

AC   CVCL_AX08

DR   ECACC; 77650300

DR   HipSci; HPSI0215i-oilg_1

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_EE41 ! HPSI0215i-oilg_3

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0215i-oilg_3

AC   CVCL_EE41

SY   WTSIi191-A

DR   BioSamples; SAMEA3485962

DR   EBiSC; WTSIi191-A

DR   ECACC; 66540417

DR   ECACC; 77650301

DR   HipSci; HPSI0215i-oilg_3

DR   hPSCreg; WTSIi191-A

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AX08 ! HPSI0215i-oilg_1

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0215i-yoch_6

AC   CVCL_EE85

DR   HipSci; HPSI0215i-yoch_6

CC   From: Cambridge BioResource; Cambridge; UK.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0313i-airc_2

AC   CVCL_AE68

SY   WTSIi105-A

DR   BioSamples; SAMEA2398371

DR   HipSci; HPSI0313i-airc_2

DR   hPSCreg; WTSIi105-A

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Cellular phenotyping.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE69 ! HPSI0313i-airc_6

OI   CVCL_AE70 ! HPSI0313i-airc_66

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0313i-airc_6

AC   CVCL_AE69

DR   HipSci; HPSI0313i-airc_6

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE68 ! HPSI0313i-airc_2

OI   CVCL_AE70 ! HPSI0313i-airc_66

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0313i-airc_66

AC   CVCL_AE70

SY   WTSIi105-B

DR   BioSamples; SAMEA2399089

DR   HipSci; HPSI0313i-airc_66

DR   hPSCreg; WTSIi105-B

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Cellular phenotyping.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE68 ! HPSI0313i-airc_2

OI   CVCL_AE69 ! HPSI0313i-airc_6

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0313i-cesj_1

AC   CVCL_AE71

SY   WTSIi108-A

DR   BioSamples; SAMEA2398465

DR   HipSci; HPSI0313i-cesj_1

DR   hPSCreg; WTSIi108-A

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0313i-fecs_1

AC   CVCL_AE72

DR   HipSci; HPSI0313i-fecs_1

CC   From: Cambridge BioResource; Cambridge; UK.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE73 ! HPSI0313i-fecs_3

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0313i-fecs_3

AC   CVCL_AE73

DR   HipSci; HPSI0313i-fecs_3

CC   From: Cambridge BioResource; Cambridge; UK.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE72 ! HPSI0313i-fecs_1

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0313i-xovo_1

AC   CVCL_AE74

DR   HipSci; HPSI0313i-xovo_1

CC   From: Cambridge BioResource; Cambridge; UK.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE75 ! HPSI0313i-xovo_2

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0313i-xovo_2

AC   CVCL_AE75

DR   HipSci; HPSI0313i-xovo_2

CC   From: Cambridge BioResource; Cambridge; UK.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE74 ! HPSI0313i-xovo_1

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0314i-bipt_1

AC   CVCL_AE76

SY   WTSIi031-A

DR   BioSamples; SAMEA2719619

DR   EBiSC; WTSIi031-A

DR   ECACC; 66540101

DR   HipSci; HPSI0314i-bipt_1

DR   hPSCreg; WTSIi031-A

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0314i-bubh_1

AC   CVCL_AE77

SY   WTSIi012-A

DR   BioSamples; SAMEA2675459

DR   EBiSC; WTSIi012-A

DR   ECACC; 66540082

DR   ECACC; 77650062

DR   HipSci; HPSI0314i-bubh_1

DR   hPSCreg; WTSIi012-A

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE78 ! HPSI0314i-bubh_3

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0314i-bubh_3

AC   CVCL_AE78

SY   WTSIi012-B

DR   BioSamples; SAMEA2698309

DR   EBiSC; WTSIi012-B

DR   ECACC; 66540181

DR   ECACC; 77650077

DR   HipSci; HPSI0314i-bubh_3

DR   hPSCreg; WTSIi012-B

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE77 ! HPSI0314i-bubh_1

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0314i-cuhk_1

AC   CVCL_AE79

SY   WTSIi077-A

DR   BioSamples; SAMEA2682671

DR   EBiSC; WTSIi077-A

DR   ECACC; 66540190

DR   ECACC; 77650049

DR   HipSci; HPSI0314i-cuhk_1

DR   hPSCreg; WTSIi077-A

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE80 ! HPSI0314i-cuhk_2

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0314i-cuhk_2

AC   CVCL_AE80

DR   HipSci; HPSI0314i-cuhk_2

CC   From: Cambridge BioResource; Cambridge; UK.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE79 ! HPSI0314i-cuhk_1

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0314i-fafq_1

AC   CVCL_AE81

SY   WTSIi078-A

DR   BioSamples; SAMEA2711371

DR   EBiSC; WTSIi078-A

DR   ECACC; 66540191

DR   ECACC; 77650090

DR   HipSci; HPSI0314i-fafq_1

DR   hPSCreg; WTSIi078-A

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0314i-hoik_1

AC   CVCL_AE82

SY   WTSIi026-A

DR   BioSamples; SAMEA2698315

DR   EBiSC; WTSIi026-A

DR   ECACC; 66540096

DR   ECACC; 77650129

DR   HipSci; HPSI0314i-hoik_1

DR   hPSCreg; WTSIi026-A

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0314i-qaqx_1

AC   CVCL_AE83

SY   WTSIi040-A

DR   BioSamples; SAMEA2658084

DR   EBiSC; WTSIi040-A

DR   ECACC; 66540036

DR   ECACC; 77650146

DR   HipSci; HPSI0314i-qaqx_1

DR   hPSCreg; WTSIi040-A

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0314i-qonc_1

AC   CVCL_AE84

SY   WTSIi011-B

DR   BioSamples; SAMEA2707499

DR   EBiSC; WTSIi011-B

DR   ECACC; 66540192

DR   ECACC; 77650084

DR   HipSci; HPSI0314i-qonc_1

DR   hPSCreg; WTSIi011-B

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE85 ! HPSI0314i-qonc_2

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0314i-qonc_2

AC   CVCL_AE85

SY   WTSIi011-A

DR   BioSamples; SAMEA2707507

DR   EBiSC; WTSIi011-A

DR   ECACC; 66540081

DR   ECACC; 77650074

DR   HipSci; HPSI0314i-qonc_2

DR   hPSCreg; WTSIi011-A

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE84 ! HPSI0314i-qonc_1

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0314i-sojd_2

AC   CVCL_AE86

SY   WTSIi073-B

DR   BioSamples; SAMEA2627571

DR   EBiSC; WTSIi073-B

DR   ECACC; 66540253

DR   ECACC; 77650184

DR   HipSci; HPSI0314i-sojd_2

DR   hPSCreg; WTSIi073-B

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE87 ! HPSI0314i-sojd_3

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0314i-sojd_3

AC   CVCL_AE87

SY   WTSIi073-A

DR   ECACC; 66540185

DR   ECACC; 77650126

DR   HipSci; HPSI0314i-sojd_3

DR   hPSCreg; WTSIi073-A

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE86 ! HPSI0314i-sojd_2

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0314i-wigw_2

AC   CVCL_EE57

SY   WTSIi179-A

DR   BioSamples; SAMEA3969710

DR   EBiSC; WTSIi179-A

DR   ECACC; 66540352

DR   ECACC; 77650315

DR   HipSci; HPSI0314i-wigw_2

DR   hPSCreg; WTSIi179-A

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0314i-xugn_1

AC   CVCL_AE88

SY   WTSIi010-A

DR   BioSamples; SAMEA2645811

DR   EBiSC; WTSIi010-A

DR   ECACC; 66540080

DR   ECACC; 77650055

DR   HipSci; HPSI0314i-xugn_1

DR   hPSCreg; WTSIi010-A

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Genome sequenced.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE89 ! HPSI0314i-xugn_2

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0314i-xugn_2

AC   CVCL_AE89

SY   WTSIi010-B

DR   BioSamples; SAMEA2645809

DR   EBiSC; WTSIi010-B

DR   ECACC; 66540111

DR   ECACC; 77650144

DR   HipSci; HPSI0314i-xugn_2

DR   hPSCreg; WTSIi010-B

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE88 ! HPSI0314i-xugn_1

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0413i-bupo_4

AC   CVCL_AE90

DR   HipSci; HPSI0413i-bupo_4

CC   From: Cambridge BioResource; Cambridge; UK.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0413i-corn_1

AC   CVCL_AE91

SY   WTSIi053-A

DR   BioSamples; SAMEA2677117

DR   EBiSC; WTSIi053-A

DR   ECACC; 66540150

DR   ECACC; 77650219

DR   HipSci; HPSI0413i-corn_1

DR   hPSCreg; WTSIi053-A

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0413i-coxy_3

AC   CVCL_AE92

SY   WTSIi109-A

DR   BioSamples; SAMEA2399264

DR   HipSci; HPSI0413i-coxy_3

DR   hPSCreg; WTSIi109-A

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Cellular phenotyping.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE93 ! HPSI0413i-coxy_33

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0413i-coxy_33

AC   CVCL_AE93

SY   WTSIi109-B

DR   BioSamples; SAMEA2398219

DR   EBiSC; WTSIi109-B

DR   ECACC; 66540234

DR   HipSci; HPSI0413i-coxy_33

DR   hPSCreg; WTSIi109-B

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE92 ! HPSI0413i-coxy_3

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0413i-gomv_3

AC   CVCL_AE94

DR   HipSci; HPSI0413i-gomv_3

CC   From: Cambridge BioResource; Cambridge; UK.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0413i-iakz_1

AC   CVCL_AE95

SY   WTSIi102-B

DR   BioSamples; SAMEA2398858

DR   HipSci; HPSI0413i-iakz_1

DR   hPSCreg; WTSIi102-B

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Cellular phenotyping.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE96 ! HPSI0413i-iakz_2

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0413i-iakz_2

AC   CVCL_AE96

SY   WTSIi102-A

DR   BioSamples; SAMEA2397889

DR   ECACC; 77650231

DR   HipSci; HPSI0413i-iakz_2

DR   hPSCreg; WTSIi102-A

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Cellular phenotyping.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE95 ! HPSI0413i-iakz_1

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0413i-nudd_1

AC   CVCL_AE97

SY   WTSIi054-A

DR   BioSamples; SAMEA2399199

DR   EBiSC; WTSIi054-A

DR   ECACC; 66540149

DR   ECACC; 77650188

DR   HipSci; HPSI0413i-nudd_1

DR   hPSCreg; WTSIi054-A

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE98 ! HPSI0413i-nudd_6

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0413i-nudd_6

AC   CVCL_AE98

SY   WTSIi054-B

DR   BioSamples; SAMEA2398822

DR   HipSci; HPSI0413i-nudd_6

DR   hPSCreg; WTSIi054-B

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE97 ! HPSI0413i-nudd_1

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0413i-ougl_1

AC   CVCL_AE99

SY   WTSIi121-A

DR   BioSamples; SAMEA2398316

DR   ECACC; 77650110

DR   HipSci; HPSI0413i-ougl_1

DR   hPSCreg; WTSIi121-A

DR   PRIDE; PXD003903

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Cellular phenotyping.

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AF00 ! HPSI0413i-ougl_3

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0413i-ougl_3

AC   CVCL_AF00

SY   WTSIi121-B

DR   BioSamples; SAMEA2398428

DR   ECACC; 77650117

DR   HipSci; HPSI0413i-ougl_3

DR   hPSCreg; WTSIi121-B

DR   PRIDE; PXD003903

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Cellular phenotyping.

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AE99 ! HPSI0413i-ougl_1

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0413i-peop_2

AC   CVCL_AF01

SY   WTSIi122-A

DR   BioSamples; SAMEA2399200

DR   HipSci; HPSI0413i-peop_2

DR   hPSCreg; WTSIi122-A

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AF02 ! HPSI0413i-peop_4

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0413i-peop_4

AC   CVCL_AF02

DR   HipSci; HPSI0413i-peop_4

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AF01 ! HPSI0413i-peop_2

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0413i-sukz_1

AC   CVCL_AF03

SY   WTSIi093-A

DR   BioSamples; SAMEA2398007

DR   EBiSC; WTSIi093-A

DR   ECACC; 66540208

DR   ECACC; 77650118

DR   HipSci; HPSI0413i-sukz_1

DR   hPSCreg; WTSIi093-A

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0413i-uahf_3

AC   CVCL_AF04

SY   WTSIi125-A

DR   BioSamples; SAMEA2397812

DR   HipSci; HPSI0413i-uahf_3

DR   hPSCreg; WTSIi125-A

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Cellular phenotyping.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0413i-xekf_1

AC   CVCL_AF05

SY   WTSIi127-A

DR   BioSamples; SAMEA2399123

DR   HipSci; HPSI0413i-xekf_1

DR   hPSCreg; WTSIi127-A

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Cellular phenotyping.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   HPSI0413i-xisg_2

AC   CVCL_AF06

DR   HipSci; HPSI0413i-xisg_2

CC   From: Cambridge BioResource; Cambridge; UK.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0413i-yotv_2

AC   CVCL_AF07

DR   ECACC; 77650153

DR   HipSci; HPSI0413i-yotv_2

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AF08 ! HPSI0413i-yotv_3

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0413i-yotv_3

AC   CVCL_AF08

DR   HipSci; HPSI0413i-yotv_3

CC   From: Cambridge BioResource; Cambridge; UK.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AF07 ! HPSI0413i-yotv_2

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0413i-yuze_1

AC   CVCL_AF09

SY   WTSIi128-A

DR   BioSamples; SAMEA2397955

DR   HipSci; HPSI0413i-yuze_1

DR   hPSCreg; WTSIi128-A

CC   From: Cambridge BioResource; Cambridge; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

CC   Omics: Cellular phenotyping.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0414i-biiw_1

AC   CVCL_AF10

SY   WTSIi192-A

DR   BioSamples; SAMEA2733282

DR   EBiSC; WTSIi192-A

DR   ECACC; 66540426

DR   ECACC; 77650333

DR   HipSci; HPSI0414i-biiw_1

CC   From: University of Exeter Medical School; Exeter; UK.

CC   From: Wellcome Trust Sanger Institute; Hinxton; UK.

DI   NCIt; C2985; Diabetes mellitus

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0414i-ceik_1

AC   CVCL_AF11

DR   HipSci; HPSI0414i-ceik_1

CC   From: Cambridge BioResource; Cambridge; UK.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AF12 ! HPSI0414i-ceik_2

SX   Male

CA   Induced pluripotent stem cell

//

ID   HPSI0414i-ceik_2

AC   CVCL_AF12

DR   HipSci; HPSI0414i-ceik_2

CC   From: Cambridge BioResource; Cambridge; UK.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AF11 ! HPSI0414i-ceik_1

SX   Male

CA   Induced pluripotent stem cell


您正在向 biovector.net  发送关于产品 细胞株Cell Lines 43-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net 的询问

点击“立即发送”后,我们将在1个工作日内与您取得联系。